{"text": "Forty - one percent of the liver transplant recipients had undergone surgery because of chronic hepatitis B or C virus infection .Ten percent of the renal transplant recipients had serologic evidence of chronic hepatitis B virus infection , and 28 percent had evidence of chronic hepatitis C virus infection .", "label": "", "metadata": {}, "score": "31.669292"}
{"text": "Fifteen patients were enrolled : 3 in arm A and 6 in arms B & C. The genotypes were : . 1a / b- 3 .", "label": "", "metadata": {}, "score": "33.731544"}
{"text": "Twenty - nine percent of 6830 patients received HCV - positive kidneys .On average , the waiting time decreased from 856 to 469 days .", "label": "", "metadata": {}, "score": "33.771454"}
{"text": "Follow - up qualitative and quantitative antibody titers were obtained after both doses of the vaccine were administered .Researchers enrolled 104 patients in the study , including 39 patients who had liver transplants , 39 patients who had kidney transplants and 29 control patients .", "label": "", "metadata": {}, "score": "34.233253"}
{"text": "The first study discussed below looks at treating individuals who appear more advanced in disease stage as they are on waiting lists for transplants .Less than half of the patients screened for the study met the criteria .", "label": "", "metadata": {}, "score": "35.278217"}
{"text": "From February 1995 through February 2003 , 28 patients ( mean age 53.8 ?10.2 years , 19 men and nine women , 16 HCV [ ? ] ; 12 HCV [ ? ] ) received HbcAb ( ? ) liver allografts .", "label": "", "metadata": {}, "score": "35.719925"}
{"text": "Abbreviations : .PATIENTS AND METHODS .Study Population .This is a prospective cohort study of 89 HIV - infected patients with chronic HCV infections and complications of end - stage liver disease who underwent transplantation at 17 US centers between October 2003 and February 2010 ( ClinicalTrials.gov number NCT00074386 ) .", "label": "", "metadata": {}, "score": "35.843357"}
{"text": "HCV - positive patients was 1.57 ( 95 % CI , 1.23 to 2.00 ) .In a study from the US , 287 anti - HCV - positive and 286 randomly selected dialysis control patients from 14 transplant centers were assessed , with a median followup of 7 years [ 23 ] .", "label": "", "metadata": {}, "score": "37.166718"}
{"text": "The number of central biopsy readings performed in the first , second , and third years after transplantation was 203 , 33 , and 15 , respectively .", "label": "", "metadata": {}, "score": "37.301476"}
{"text": "Only 3 of the 51 patients developed cirrhosis during long - term followup .Nonetheless , liver biopsy remains the gold standard to assess the progression of HCV - related liver disease after kidney transplantation .", "label": "", "metadata": {}, "score": "37.71591"}
{"text": "Fourteen of the 78 individuals ( 18 % ) who were nonviremic at the baseline had 2 or more consecutive detectable measurements after transplantation .HIV RNA was detectable at the most recent follow - up visit in 9 of the cases ( 5 at the time of graft loss ) .", "label": "", "metadata": {}, "score": "38.564224"}
{"text": "Liver recipients will have an initial screening assessment consisting of a medical history , liver biopsy , and urine and blood collection .Eligible recipients will be placed on a modified medication schedule to gradually decrease their immunosuppression medication slowly over a 9- to 12-month period , during which time they will be closely monitored by study staff .", "label": "", "metadata": {}, "score": "38.86564"}
{"text": "Several single center studies had shown similar short - term graft and patient survival with no increase in acute rejection compared to those who received HCV - negative kidneys [ 58 ] .", "label": "", "metadata": {}, "score": "39.239986"}
{"text": "However , HCV - positive kidney transplant recipients experienced lower long - term graft and patient survival compared to their HCV - negative counterparts [ 7 - 9 ] .", "label": "", "metadata": {}, "score": "39.310863"}
{"text": "Three deaths in HCV - positive kidney recipients and 2 in HCV - negative kidney recipients were related to liver disease .There was no statistically significant difference in the 5- and 10-year death - censored graft survival , 69 % and 47 % in the HCV - positive kidney recipients versus 72.7 % and 58.5 % in the HCV - negative kidney recipients , .", "label": "", "metadata": {}, "score": "39.5042"}
{"text": "Seventeen patients received standard steroid taper .There was also no difference in acute rejection episodes and post - transplant liver abnormalities between the 2 groups .", "label": "", "metadata": {}, "score": "40.153976"}
{"text": "Although this study represents the largest US experience with the transplantation of HIV / HCV - coinfected patients , its limitations include a lack of a uniform immunosuppressive regimen and standard antiretroviral therapy followed by all centers .", "label": "", "metadata": {}, "score": "40.173325"}
{"text": "Three patients lost their grafts due to hepatic artery thrombosis and had to be retransplanted .The actuarial graft survival at 6 years was 63.9 % ( Fig 1A ) .", "label": "", "metadata": {}, "score": "40.52506"}
{"text": "The overall 6-year actuarial graft survival was 63.9 % and those for HCV ( ? ) and HCV ( ? ) recipients were 68.8 % and 57.1 % , respectively ( P ?", "label": "", "metadata": {}, "score": "40.946342"}
{"text": "The 6-year actuarial graft survivals for HCV ( ? ) and HCV ( ? ) recipients were 57.8 % and 68.8 % , respectively ( P ?", "label": "", "metadata": {}, "score": "41.01844"}
{"text": "Two of them developed persistent viremia with HEV genotype 3 .The patients were anti - HEV immunoglobulin G - negative and HEV RNA - negative before transplantation and had an episode of acute hepatitis 5 or 7 months after transplantation , which led to advanced liver fibrosis after 22 months in 1 patient .", "label": "", "metadata": {}, "score": "41.192528"}
{"text": "In a multicenter prospective study from Japan , 1,470 patients ( 19 % positive for anti - HCV ) from 16 dialysis centers were followed up for an average of 6 years .", "label": "", "metadata": {}, "score": "41.745834"}
{"text": "The purpose of this study is to determine whether immunosuppressive drugs can be safely withdrawn over a minimum of 9 months from children who received liver transplants at least 4 years ago .", "label": "", "metadata": {}, "score": "42.04309"}
{"text": "Two patients were on long - term dialysis with compensated cirrhosis ; the remainder had decompensated cirrhosis with acute or acute - on - chronic kidney disease .", "label": "", "metadata": {}, "score": "42.67254"}
{"text": "Today , more than 18,000 patients , including children , in the United States are waiting for a new liver .As new surgical techniques and better immunosuppressant drugs are developed , more patients with liver disease have become eligible for a transplant , but the number of deceased donors can not keep up with that demand .", "label": "", "metadata": {}, "score": "42.892136"}
{"text": "226 HBV - monoinfected patients , not undergoing antiviral therapy , were analyzed in a cross - sectional study . HBsAg was quantified and correlated with HBV - DNA , HBV - genotypes and clinical parameters .", "label": "", "metadata": {}, "score": "43.562843"}
{"text": "We questioned if chronic hepatitis E plays a role in graft hepatitis after liver transplantation in a low endemic area .Two hundred twenty - six liver transplant recipients , 129 nontransplanted patients with chronic liver disease , and 108 healthy controls were tested for HEV antibodies .", "label": "", "metadata": {}, "score": "43.5979"}
{"text": "HCV Disease Severity .Sixty - two percent of the HCV / HIV - coinfected recipients and 64 % of the HCV - infected recipients had 2 or more biopsy samples for review .", "label": "", "metadata": {}, "score": "43.737892"}
{"text": "In conclusion , we conclude that HBcAb ( ? ) liver grafts can be used for both HCV ( ? ) patients and HCV ( ? ) patients who are critically ill , have early HCC , or have been exposed to HBV in the past .", "label": "", "metadata": {}, "score": "43.780407"}
{"text": "( C ) Graft survival for the HCV ( ? ) and HCV ( ? ) recipient groups .Recipient patient and graft survival statistics for HB- 3188 JAIN , ORLOFF , ABT ET AL .", "label": "", "metadata": {}, "score": "43.819435"}
{"text": "Full dose 3 - 6 months .RELATIONSHIP TO DOSE .There were 57 patients with genotype 1 .19 of the 86 patients were transplanted .", "label": "", "metadata": {}, "score": "44.150486"}
{"text": "75 enrolled and began treatment .Some patients had transplants and some were non - adherent .21 patients dropped out . of the 25 that cleared RNA 12 relapsed and treatment was discontinued .", "label": "", "metadata": {}, "score": "44.383453"}
{"text": "193 - 200 , 1994 .View at Google Scholar \u00b7 View at Scopus .T. Poynard , F. Imbert - Bismut , V. Ratziu et al . , \" Biochemical markers of liver fibrosis in patients infected by hepatitis C virus : longitudinal validation in a randomized trial , \" Journal of Viral Hepatitis , vol .", "label": "", "metadata": {}, "score": "44.856842"}
{"text": "274 HTR were prospectively screened for HEV infection using an anti - HEV - IgG ELISA and HEV - PCR .In addition , 137 patients undergoing cardiac surgery ( non - HTR ) and 537 healthy subjects were studied cross - sectionally .", "label": "", "metadata": {}, "score": "45.17615"}
{"text": "The recipients were 19 men and nine women of mean age 53.8 ?10.2 years .The primary reason for use of HBcAb ( ? ) donor grafts were as follows : critically ill recipient ( n ? 11 ) , HCC stage I / II ( n ? 6 ) , and HBcAb ( ? ) recipient ( n ?", "label": "", "metadata": {}, "score": "45.202217"}
{"text": "Death from liver disease occurred in 14 % of anti - HCV - positive and only 2 % of anti - HCV - negative controls .", "label": "", "metadata": {}, "score": "45.223145"}
{"text": "69 , no . 7 , pp .1479 - 1484 , 2000 .View at Google Scholar \u00b7 View at Scopus . D. Roth , R. Cirocco , R. Reddy , et al . , \" Ten year prospective study of hepatitis C virus infection in kidney transplant recipients , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "45.34202"}
{"text": "One patient died from a fatal complication .But individuals were capable of a virologic response .The second study below looks at individuals who appear not to be as progressed in their liver disease and the investigator also saw a viral response , but the complications and side effects were not as severe .", "label": "", "metadata": {}, "score": "45.506733"}
{"text": "The rates of sustained virological response were similar for the 2 groups : 13.5 % ( 5/37 ) for the HCV / HIV - coinfected group and 15.8 % ( 9/57 ) for the HCV - monoinfected group .", "label": "", "metadata": {}, "score": "45.53459"}
{"text": "Two patients at the time of closing the study went on to transplantation .One patient had undetectable VL by bDNA assay at the time of transplant but within 1 month the VL went up to 42 million .", "label": "", "metadata": {}, "score": "45.54213"}
{"text": "Recipients of parental living donor liver transplants 4 or more years prior to trial enrollment , who also had stable allograft function during the preceding 6 months while taking a single immunosuppressive drug were permitted to undergo withdrawal of immunosuppression therapy .", "label": "", "metadata": {}, "score": "45.57589"}
{"text": "74 - 78 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Kamar , K. Sandres - Saune , J. Selves et al . , \" Long - term ribavirin therapy in hepatitis C virus - positive renal transplant patients : effects on renal function and liver histology , \" American Journal of Kidney Diseases , vol .", "label": "", "metadata": {}, "score": "45.64482"}
{"text": "146 - 153 , 1999 .View at Google Scholar \u00b7 View at Scopus .J. M. Cruzado , M. Carrera , J. Torras , and J. M. Griny\u00f3 , \" Hepatitis C virus infection and de novo glomerular lesions in renal allografts , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "45.89868"}
{"text": "The incidence of decompensated liver disease was also not different between the 2 groups : 10.3 % versus 6.2 % .Donor HCV serology was not found to be a risk factor for death , graft failure and severe liver disease [ 60 ] .", "label": "", "metadata": {}, "score": "45.899113"}
{"text": "An update of the long - term experience from Spain using HCV - positive kidney donor was reported [ 60 ] .There was no difference in the 5- and 10-year patient survival between 162 recipients of HCV - positive kidneys versus 306 recipients of HCV - negative kidneys : 84.8 % and 72.7 % versus 86.6 % and 76.5 % , respectively , .", "label": "", "metadata": {}, "score": "45.98114"}
{"text": "6 , pp . 1452 - 1461 , 2005 .View at Publisher \u00b7 View at Google Scholar .M. R. Weir , R. L. Kirkman , T. B. Strom , and N. L. Tilney , \" Liver disease in recipients of long - functioning renal allografts , \" Kidney International , vol .", "label": "", "metadata": {}, "score": "46.09335"}
{"text": "Posttransplant Follow - Up in the HCV / HIV Cohort .A standardized protocol for posttransplant follow - up was used .Liver biopsy samples were obtained at least annually to assess HCV disease severity , and they were read centrally and scored with the Ludwig - Batts method . 13", "label": "", "metadata": {}, "score": "46.262028"}
{"text": "To prevent potential biases in selection , we carefully matched the HCV - monoinfected patients by center , year of transplantation , and key recipient factors .", "label": "", "metadata": {}, "score": "46.334106"}
{"text": "This study will determine whether gradual withdrawal and eventual discontinuation of all immunosuppressive medication can be safely accomplished in children who received a liver transplant from a parent .", "label": "", "metadata": {}, "score": "46.42063"}
{"text": "This contrasts with a previous study from France indicating more severe HCV disease in coinfected patients .5 The rates of advanced fibrosis ( F3-F4 ) were 20 % ( 4/20 ) and 57 % ( 8/14 ) in the HCV / HIV - coinfected French cohort compared to 17 % and 27 % in our cohort , 1 and 2 years after transplantation , respectively .", "label": "", "metadata": {}, "score": "46.51255"}
{"text": "17 The number of biopsy readings performed in the first , second , and third years after transplantation was 382 , 136 , and 60 , respectively .", "label": "", "metadata": {}, "score": "46.60488"}
{"text": "11 , pp .2469- 2475 , 1996 .View at Google Scholar \u00b7 View at Scopus . D. Roth , R. Cirocco , K. Zucker et al . , \" De novo membranoproliferative glomerulonephritis in hepatitis C virus- infected renal allograft recipients , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "46.796837"}
{"text": "To date , no study has From the Department of Surgery , Division of Transplantation , Strong Memorial Hospital , Rochester , New York , USA .", "label": "", "metadata": {}, "score": "46.8469"}
{"text": "Most of the liver transplant recipients were taking only one immunosuppressive medication , while all of the kidney transplant recipients were taking two or more immunosuppressive agents .", "label": "", "metadata": {}, "score": "46.945694"}
{"text": "11 , pp .1550 - 1555 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Canbakan , H. Senturk , B. Canbakan et al . , \" Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C , \" Nephron - Clinical Practice , vol .", "label": "", "metadata": {}, "score": "46.95612"}
{"text": "One study found that 35 percent of patients with hepatitis C died after developing HAV infection .A high prevalence of hepatitis B and C virus infection has been noted among many transplant recipients .", "label": "", "metadata": {}, "score": "47.01555"}
{"text": "90 , no .11 , pp .1165 - 1171 , 2010 .View at Google Scholar .N. A. Terrault and D. B. Adey , \" The kidney transplant recipient with hepatitis C infection : pre- and posttransplantation treatment , \" Clinical Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "47.11589"}
{"text": "The 6-year actuarial patient survivals for HCV ( ? ) and HCV ( ? ) groups were 66.6 % and 81.3 % , respectively ( P ? .46 ; Fig 1B ) .", "label": "", "metadata": {}, "score": "47.142082"}
{"text": "Liver Int .[ Google Scholar ] [ CrossRef ] .Venu , M. ; Martin , E. ; Saeian , K. ; Gawrieh , S. High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation .", "label": "", "metadata": {}, "score": "47.177074"}
{"text": "The treatment consisted of 50,000 International Units per week for eight weeks .Thereafter , the patients received 50,000 International Units every month for two months .", "label": "", "metadata": {}, "score": "47.28379"}
{"text": "128 - 133 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. L. Schiavon , J. L. N. Schiavon , R. J. Carvalho Filho et al . , \" Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "47.3126"}
{"text": "12 , pp .1676 - 1682 , 1995 .View at Google Scholar \u00b7 View at Scopus .J. M. Morales , J. M. Campistol , A. Andr\u00e9s , and J. L. Rodicio , \" Glomerular diseases in patients with hepatitis C virus infection after renal transplantation , \" Current Opinion in Nephrology and Hypertension , vol .", "label": "", "metadata": {}, "score": "47.50596"}
{"text": "14 , 15 Health care providers followed calcineurin inhibitor dosing guidelines for patients on protease inhibitors ( PIs ) or on combined regimens based on PIs and nonnucleoside reverse transcriptase inhibitors ( NNRTIs ) .", "label": "", "metadata": {}, "score": "47.514153"}
{"text": "Of the patients , 45.7 % were male ; 87.3 % had migrated to Germany from the Eastern Mediterranean area and 12.0 % from Eastern Europe .", "label": "", "metadata": {}, "score": "47.61231"}
{"text": "We conclude that HBcAb ( ? ) liver grafts can be used for both HCV ( ? ) patients and HCV ( ? ) patients who are critically ill , have early hepatocellular carcinoma , or have been exposed to HBV in the past .", "label": "", "metadata": {}, "score": "47.654"}
{"text": "55 - 60 , 1999 .View at Google Scholar \u00b7 View at Scopus .T. Tokumoto , K. Tanabe , and K. Tanabe , \" Effect of interferon - alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "47.74042"}
{"text": "Three recipients ( 10.7 % ) developed HBV infection during follow - up , one of whom died 36 months after LTx and the other two had YMDD mutant HBV .", "label": "", "metadata": {}, "score": "47.840508"}
{"text": "At three months after liver transplantation , Reese and colleagues observed a marked increase in serum calcidiol levels with a median change of 17.8 ng / mL ( interquartile range 8.6 to 25.9 ng / mL ) .", "label": "", "metadata": {}, "score": "47.844597"}
{"text": "The present study focused on liver transplants with a HBcAb ( ? ) liver allograft alone at our center during the study period .These donors were further screened for HBcAb immunoglobulin ( Ig ) and HB- cAb IgM and all grafts that were HBsAg ( ? ) or HBcAb IgM ( ? ) were excluded from transplantation .", "label": "", "metadata": {}, "score": "47.906666"}
{"text": "5 , pp .1494 - 1499 , 2002 .View at Google Scholar \u00b7 View at Scopus .N. Kamar , L. Rostaing , J. Selves et al . , \" Natural history of hepatitis C virus - related liver fibrosis after renal transplantation , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "47.912605"}
{"text": "Estimated rates of patient survival , graft survival , graft rejection , and severe HCV recurrence were calculated with the Kaplan - Meier method , and 95 % confidence intervals ( CIs ) were estimated with Greenwood 's formula .", "label": "", "metadata": {}, "score": "48.253433"}
{"text": "6 , pp .274 - 278 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Ahmad , F. Hasan , S. Abdeen et al . , \" Transjugular liver biopsy in patients with end - stage renal disease , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "48.429054"}
{"text": "Liver Transpl 9:837 , 2003 HEPATITIS B CORE ANTIGEN3189 .Data provided are for informational purposes only .Although carefully collected , accuracy can not be guaranteed .", "label": "", "metadata": {}, "score": "48.454857"}
{"text": "One of these recipients died of liver failure from HBV infection 36 months after LTx .HBV - DNA results from the other two patients revealed YMDD mutation .", "label": "", "metadata": {}, "score": "48.550278"}
{"text": "1479 - 1484 , 2000 .View at Google Scholar \u00b7 View at Scopus .S. Pawa , M. Ehrinpreis , M. Mutchnick , J. Janisse , R. Dhar , and F. A. Siddiqui , \" Percutaneous liver biopsy is safe in chronic hepatitis C patients with end - stage renal disease , \" Clinical Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "48.790665"}
{"text": "5 , pp .360 - 369 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Mu\u00f1oz , E. Ram\u00edrez , I. Fernandez et al . , \" Correlation between fibroscan , liver biopsy , and clinical liver function in patients with hepatitis C virus infection after renal transplantation , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "48.895836"}
{"text": "146 - 153 , 1999 .View at Google Scholar \u00b7 View at Scopus . F. G. Cosio , D. D. Sedmak , M. L. Henry et al . , \" The high prevalence of severe early posttransplant renal allograft pathology inhepatitis C positive recipients , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "48.989563"}
{"text": "In 63 patients who did not receive IFN , 28.7 % had negative HCV - PCR .Twelve of these 63 patients developed de novo glomerulonephritis .", "label": "", "metadata": {}, "score": "49.0105"}
{"text": "437 - 443 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Cruzado , T. Casanovas - Taltavull , J. Torras , C. Baliellas , S. Gil - Vernet , and J. M. Griny\u00f3 , \" Pretransplant interferon prevents hepatitis C virus - associated glomerulonephritis in renal allografts by HCV - RNA clearance , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "49.096027"}
{"text": "5 , pp .1238 - 1246 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Morales , J. M. Campistol , B. Dom\u00ednguez - Gil et al . , \" Long - term experience with kidney transplantation from hepatitis C - positive donors into hepatitis C - positive recipients , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "49.255985"}
{"text": "52 - 61 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Morales , B. Dom\u00ednguez - Gil , D. Sanz - Guajardo , J. Fern\u00e1ndez , and F. Escuin , \" The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "49.27368"}
{"text": "6 , pp .2425 - 2426 , 2009 .View at Publisher \u00b7 View at Google Scholar . D. Hestin , F. Guillemin , N. Castin , A. Le Faou , J. Champigneulles , and M. Kessler , \" Pretransplant hepatitis C virus infection : a predictor of proteinuria after renal transplantation , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "49.28173"}
{"text": "171 - 178 , 2001 .View at Google Scholar \u00b7 View at Scopus .J.-L. Garnier , P. Chevallier , J.-M. Dubernard , C. Trepo , J.-L. Touraine , and P. Chossegros , \" Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "49.348404"}
{"text": "11 , pp .2453 - 2462 , 2010 .View at Publisher \u00b7 View at Google Scholar .T. Schussler , C. Staffeld - Coit , J. Eason , and S. Nair , \" Severe hepatitis C infection in a renal transplant recipient following hepatitis C genotype mismatch transplant , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "49.36882"}
{"text": "iii72-iii76 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Cruzado , M. Carrera , J. Torras , and J. M. Griny\u00f3 , \" hepatitis C virus infection and de novo glomerular lesions in renal allografts , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "49.45391"}
{"text": "6 , pp .594 - 601 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Martin , D. Carter , F. Fabrizi et al . , \" Histopathological features of hepatitis C in renal transplant candidates , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "49.45525"}
{"text": "Donor information was obtained from SRTR ; recipient information and posttransplant complications , including HCV disease severity by liver biopsy , the treatment of HCV and acute cellular rejection , and the causes of graft loss and patient death , were obtained by medical chart review .", "label": "", "metadata": {}, "score": "49.567924"}
{"text": "A lack of detailed biopsy grading information before treatment for the HCV - monoinfected patients precluded a comparison of the stages of disease at treatment initiation .", "label": "", "metadata": {}, "score": "49.626583"}
{"text": "We aimed to study the role of HEV infections in heart transplant recipients ( HTR ) .274 HTR were prospectively screened for HEV infection using an anti - HEV - IgG ELISA and HEV - PCR .", "label": "", "metadata": {}, "score": "49.682316"}
{"text": "HCV RNA was detected in 9 of the 11 anti - HCV - positive patients , while HBV DNA tested positive in all 7 HBsAg - positive patients .", "label": "", "metadata": {}, "score": "49.783752"}
{"text": "Comparison was made of concordance and performance of four licensed anti - HCV assays in samples with borderline signal - to - cut - off ratios .", "label": "", "metadata": {}, "score": "49.88453"}
{"text": "141 - 144 , 1998 .View at Google Scholar \u00b7 View at Scopus .J. M. Campistol , N. Esforzado , and N. Esforzado , \" Efficacy and tolerance of interferon- \u03b1 2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients . Pre- and post - renal transplantation assessment , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "50.004852"}
{"text": "18 - 20 Among the HCV / HIV patients in this study , older donor age was also associated with higher rates of graft loss , as was the use of anti - HCV - positive donors .", "label": "", "metadata": {}, "score": "50.057323"}
{"text": "4 , pp .442 - 450 , 2003 .View at Google Scholar .O. Alfurayh , M. Sobh , A. R. Buali , M. Ashraf Ali , Y. Barri , W. Qunibi , and S. Taher , \" Hepatitis C virus infection in chronic haemodialysis patients , a clinicopathologic study , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "50.072227"}
{"text": "At three months after transplantation , vitamin D deficiency was more prevalent among black liver transplant recipients as compared with non - black patients ( 38 % vs. 20 % ) [ 36 ] .", "label": "", "metadata": {}, "score": "50.137653"}
{"text": "Liver Transpl 2009 ; 15 : 738 - 746 .19 Lake JR , Shorr JS , Steffen BJ , Chu AH , Gordon RD , Wiesner RH .", "label": "", "metadata": {}, "score": "50.205605"}
{"text": "11 , pp . 1634 - 1639 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Hestin , F. Guillemin , N. Castin , A. Le Faou , J. Champigneulles , and M. Kessler , \" Pretransplant hepatitis C virus infection : a predictor of proteinuria after renal transplantation , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "50.21814"}
{"text": "Liver Transpl 2002 ; 8 : 841 - 845 .27 Colloredo G , Guido M , Sonzogni A , Leandro G .Impact of liver biopsy size on histological evaluation of chronic viral hepatitis : the smaller the sample , the milder the disease .", "label": "", "metadata": {}, "score": "50.27986"}
{"text": "Even though intake of 400 to 800 International Units of vitamin D was recommended to all patients , approximately three quarters of the patients displayed vitamin D insufficiency at one year post - transplant [ 16 ] .", "label": "", "metadata": {}, "score": "50.29861"}
{"text": "J. Med .[ Google Scholar ] [ CrossRef ] .Tschopp , O. ; Boehler , A. ; Speich , R. ; Weder , W. ; Seifert , B. ; Russi , E.W. ; Schmid , C. Osteoporosis before lung transplantation : Association with low body mass index , but not with underlying disease .", "label": "", "metadata": {}, "score": "50.300842"}
{"text": "No major complications were observed in the patients who underwent TJLB compared with a 12 % bleeding complication rate in the percutaneous liver biopsy group .", "label": "", "metadata": {}, "score": "50.309082"}
{"text": "429 - 433 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . F. Nicot , N. Kamar , B. Mariam\u00e9 , L. Rostaing , C. Pasquier , and J. Izopet , \" No evidence of occult hepatitis C virus ( HCV ) infection in serum of HCV antibody - positive HCV RNA - negative kidney - transplant patients , \" Transplant International , vol .", "label": "", "metadata": {}, "score": "50.42356"}
{"text": "The early experience in 2 transplant centers in Spain showed transmission of HCV RNA in HCV antibody - positive recipients who were negative for HCV RNA [ 60 ] .", "label": "", "metadata": {}, "score": "50.503162"}
{"text": "5 , pp .741 - 744 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Cruzado , S. Gil - Vernet , G. Ercilla et al . , \" hepatitis C virus - associated membranoproliferative glomerulonephritis in renal allografts , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "50.534203"}
{"text": "13 Peter G. Stock , Norah A. Terrault , Human immunodeficiency virus and liver transplantation : Hepatitis C is the last hurdle , Hepatology , 2015 , 61 , 5 , 1747 Wiley Online Library .", "label": "", "metadata": {}, "score": "50.622738"}
{"text": "The efficacy and safety of a rapid steroid tapering regimen under antilymphocyte antibody induction was studied in HCV - positive kidney transplant recipients [ 64 ] .", "label": "", "metadata": {}, "score": "50.729942"}
{"text": "[ 59 ] .However , this hazard ratio only translated into a difference of 1 % in 1-year survival between HCV - negative and HCV - positive kidney recipients ( 94 % versus 93 % ) and a 2 % difference in 3 year survival ( 85 % versus 83 % ) .", "label": "", "metadata": {}, "score": "50.811466"}
{"text": "4 , pp .195 - 203 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. M. Kucirka , A. L. Singer , R. L. Ros , R. A. Montgomery , N. N. Dagher , and D. L. Segev , \" Underutilization of hepatitis C - positive kidneys for hepatitis C - positive recipients , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "50.83083"}
{"text": "4 , pp .1170 - 1177 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Kamar , O. Toupance , M. Buchler , et al . , \" Evidence that clearance of hepatitis C virus RNA after alpha - interferon therapy in dialysis patients is sustained after renal transplantation , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "51.11611"}
{"text": "12 , pp .2244 - 2252 , 1998 .View at Google Scholar \u00b7 View at Scopus . S. Baid , A. B. Cosimi , N. Tolkoff - Rubin , R. B. Colvin , W. W. Williams , and M. Pascual , \" Renal disease associated with hepatitis C infection after kidney and liver transplantation , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "51.152695"}
{"text": "All samples were re - tested with the Enzygnost Anti - HCV version 4.0 , the Ortho anti - HCV version 3.0 , and the Monolisa anti - HCV - Plus version 2 assays .", "label": "", "metadata": {}, "score": "51.162106"}
{"text": "15 , pp .1919 - 1927 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Dom\u00ednguez - Gil , N. Esforzado , J. M. Campistol , A. Andres , and J. M. Morales , \" Use of hepatitis C - positive donors for kidney transplantation , \" Transplantation Reviews , vol .", "label": "", "metadata": {}, "score": "51.352436"}
{"text": "Another patient developed a culture negative empyema that progressed to multi - system organ failure , refractory hypotension and death despite aggressive ( antibiotic ) medical therapy .", "label": "", "metadata": {}, "score": "51.552067"}
{"text": "257 - 260 , 2004 .View at Google Scholar \u00b7 View at Scopus . A. Varaut , H. Fontaine , J. Serpaggi et al . , \" Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "51.6577"}
{"text": "J. Heart Lung Transplant .[ Google Scholar ] .Shane , E. ; Silverberg , S.J. ; Donovan , D. ; Papadopoulos , A. ; Staron , R.B. ; Addesso , V. ; Jorgesen , B. ; McGregor , C. ; Schulman , L. Osteoporosis in lung transplantation candidates with end - stage pulmonary disease .", "label": "", "metadata": {}, "score": "51.728043"}
{"text": "Liver Int .[ Google Scholar ] [ CrossRef ] .Osteoporos .Int .[ Google Scholar ] [ CrossRef ] .Segal , E. ; Baruch , Y. ; Kramsky , R. ; Raz , B. ; Tamir , A. ; Ish - Shalom , S. Predominant factors associated with bone loss in liver transplant patients - After prolonged post - transplantation period .", "label": "", "metadata": {}, "score": "51.790363"}
{"text": "The mean donor age for the study group was 53.6 ?15.8 years .Each of the 28 patients received a short course of intravenous HBIg prophylaxis ( 10,000 units daily for 4 days ) and long - term lamivudine 100 mg / day after LTx .", "label": "", "metadata": {}, "score": "51.84021"}
{"text": "We and others have previously shown an HCV RNA decline during haemodialysis ; however , limited data on HBV viraemia during haemodialysis are available .A total of 142 haemodialysis patients participated in this study , 11 were anti - HCV positive and 7 were HBsAg positive .", "label": "", "metadata": {}, "score": "51.97232"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. Alric , V. DiMartino , J. Selves et al . , \" Long - term impact of renal transplantation on liver fibrosis during hepatitis C virus infection , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "52.02521"}
{"text": "A subgroup - analysis revealed that the proportion of vitamin D insufficient patients was similar between patients with one , two , three or four years of follow - up ( ranging from 42 % at one and two years post - transplant to 53 % at three and four years post - transplant ) .", "label": "", "metadata": {}, "score": "52.132942"}
{"text": "4 , pp .327 - 332 , 1992 .View at Google Scholar \u00b7 View at Scopus . A. Mitwalli , S. Al - Mohaya , J. Al Wakeel , H. El Gamal , V. Rotimi , A. Al - Zeben , and A. Al - Aska , \" Hepatitis C in chronic renal failure patients , \" American Journal of Nephrology , vol .", "label": "", "metadata": {}, "score": "52.15181"}
{"text": "Intake of 400 to 800 International Units of vitamin D was recommended to all patients .Still , approximately half of the patients displayed vitamin D insufficiency at one year post - transplant [ 16 ] .", "label": "", "metadata": {}, "score": "52.152977"}
{"text": "Two non - HIV control groups were used for analytical purposes .This control group was used for comparisons of survival , rejection , and HCV recurrence .", "label": "", "metadata": {}, "score": "52.18709"}
{"text": "Of note , the control patients reported the largest number of side effects .The authors conclude that the administration of hepatitis A vaccine is safe and immunogenic in kidney or liver transplant recipients .", "label": "", "metadata": {}, "score": "52.2415"}
{"text": "1054 - 1059 , 1996 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Baid , N. Tolkoff - Rubin , S. Saidman et al . , \" Acute humoral rejection in hepatitis C - infected renal transplant recipients receiving antiviral therapy , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "52.25715"}
{"text": "11 , pp .2704 - 2709 , 1999 .View at Google Scholar \u00b7 View at Scopus .S. Huraib , D. Tanimu , S. A. Romeh , K. Quadri , G. Al Ghamdi , A. Iqbal , and A. Abdulla , \" Interferon- \u03b1 in chronic hepatitis C infection in dialysis patients , \" American Journal of Kidney Diseases , vol .", "label": "", "metadata": {}, "score": "52.26516"}
{"text": "6 , pp .511 - 515 , 1997 .View at Google Scholar \u00b7 View at Scopus .N. Kamar , L. Rostaing , A. Boulestin et al . , \" Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis , \" Journal of Medical Virology , vol .", "label": "", "metadata": {}, "score": "52.294094"}
{"text": "171 - 178 , 2001 .View at Google Scholar \u00b7 View at Scopus .F. Fabrizi , P. Martin , V. Dixit , S. Bunnapradist , and G. Dulai , \" hepatitis C virus antibody status and survival after renal transplantation : meta - analysis of observational studies , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "52.347435"}
{"text": "We have been performing this procedure since 1997 .Our pioneering research has dramatically improved survival rates and post - transplant quality of life .We have research underway on artificial liver support devices , hepatocellular carcinoma ( liver cancer ) , split - liver transplantation ( a process where two recipients are provided with liver from one donor ) and living - donor liver transplantation .", "label": "", "metadata": {}, "score": "52.35054"}
{"text": "[ 10 ] .Hepatocellular carcinoma and liver cirrhosis were the more frequent causes of death in HCV - positive patients [ 10 ] .Indeed , liver failure has been reported as a cause of death in 8 % to 28 % of long - term kidney transplant survivors [ 11 - 13 ] .", "label": "", "metadata": {}, "score": "52.354137"}
{"text": "56 , pp .700 - 706 , 1999 .View at Google Scholar .T. Casanovas Taltavull , C. Baliellas Comellas , and J. M. Cruzado Garrit , \" Results of hepatitis C virus treatment in patients on hemodialysis : data from published meta - analyses in 2008 , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "52.46176"}
{"text": "Results for the HCV ( ? ) and HCV ( ? )Recipients As noted , 12 patients were HCV ( ? ) and 16 were HCV ( ? )", "label": "", "metadata": {}, "score": "52.508057"}
{"text": "4 , pp .482 - 488 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Baid , M. Pascual , W. W. Williams et al . , \" Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C - positive renal allograft recipients , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "52.63614"}
{"text": "Transplantation 2011 , 92 , 106 - 111 .[ Google Scholar ] [ CrossRef ] .Schleithoff , S.S. ; Zittermann , A. ; Tenderich , G. ; Berthold , H.K. ; Stehle , P. ; Koerfer , R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure : A double - blind , randomized , placebo - controlled trial .", "label": "", "metadata": {}, "score": "52.702164"}
{"text": "One case of cutaneous Kaposi 's sarcoma was treated successfully with a change to sirolimus - based immunosuppression .Ten of the 11 subjects with detectable HIV RNA at the baseline had undetectable levels within 3 months , and 1 subject had undetectable levels 9 months after transplantation .", "label": "", "metadata": {}, "score": "52.97715"}
{"text": "Liver - related deaths in persons infected with the human immunodeficiency virus : the D : A : D study .Arch Intern Med 2006 ; 166 : 1632 - 1641 .", "label": "", "metadata": {}, "score": "53.0343"}
{"text": "Transplant .[ Google Scholar ] .Holick , M.F. ; Binkley , N.C. ; Bischoff - Ferrari , H.A. ; Gordon , C.M. ; Hanley , D.A. ; Heaney , R.P. ; Murad , M.H. ; Weaver , C.M. Evaluation , treatment , and prevention of vitamin D deficiency : An Endocrine Society clinical practice guideline .", "label": "", "metadata": {}, "score": "53.048897"}
{"text": "Vitamin D deficiency at the time of transplantation was associated with an increased risk of experiencing acute rejection episodes or infections [ 25 ] .Similarly , a European study reported an improvement in vitamin D status after one year of lung transplantation .", "label": "", "metadata": {}, "score": "53.118317"}
{"text": "We observed lower patient and graft survivals with use of HBcAb ( ? ) in HCV ( ? ) recipients compared to HCV ( ? ) , but the differences were not statistically significant and these results were due to patient characteristics rather than donor characteristics , since none of the HCV ( ? )", "label": "", "metadata": {}, "score": "53.20861"}
{"text": "575 - 580 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. H. Liu , C. C. Liang , J. W. Lin et al . , \" Pegylated interferon \u03b1 -2a versus standard interferon \u03b1 -2a for treatment - na\u00efve dialysis patients with chronic hepatitis C : a randomised study , \" Gut , vol .", "label": "", "metadata": {}, "score": "53.227386"}
{"text": "All patients had genotype 4 infection , SVR rate was significantly higher with nitazoxanide ( 17 versus 0 percent ) .SVR rates were 79 percent in the triple therapy arm , 61 percent in the nitazoxanide / peginterferon arm , and 50 percent in the standard of care arm .", "label": "", "metadata": {}, "score": "53.235535"}
{"text": "Transplantation 2004 ; 78 : 966 - 971 .15Rosen HR , Shackleton CR , Higa L , Gralnek IM , Farmer DA , McDiarmid SV , et al .", "label": "", "metadata": {}, "score": "53.237686"}
{"text": "Of the 4 SVRs for whom data is available so far remain RNA- after transplant .And they have basically normal ALT & liver function .", "label": "", "metadata": {}, "score": "53.426876"}
{"text": "6 , pp .1614 - 1617 , 1997 .View at Google Scholar \u00b7 View at Scopus . A. Rodrigues , T. Morgado , and T. Morgado , \" Limited benefits of INF- \u03b1 therapy in renal graft candidates with chronic viral hepatitis B or C , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "53.431015"}
{"text": "[ Google Scholar ] .Euvrard , S. ; Kanitakis , J. ; Claudy , A. Skin cancers after organ transplantation .N. Engl .J. Med .", "label": "", "metadata": {}, "score": "53.499596"}
{"text": "Second , donor selection is important .Older donors are already recognized as a risk for HCV - infected transplant recipients , and coinfected patients have higher rates of graft loss with older donors also .", "label": "", "metadata": {}, "score": "53.611366"}
{"text": "Results .Seven ( 25 % ) of the 28 recipients died during follow - up and three recipients required retransplantation .Three recipients ( 10.7 % ) developed HBV infection during follow - up , one of whom died 36 months after LTx and the other two had YMDD mutant HBV .", "label": "", "metadata": {}, "score": "53.6456"}
{"text": "There is considerable variability in the prevalence of anti - HCV and chronic HCV infection in dialysis units worldwide , ranging from as low as 1 % to as high as 95 % .", "label": "", "metadata": {}, "score": "53.66042"}
{"text": "11 , pp .1316 - 1320 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. \u0160abovi\u010d , B. Salobir , I. P. Zupan , P. Bratina , V. Bojec , and J. B. Ponikvar , \" The influence of the haemodialysis procedure on platelets , coagulation and fibrinolysis , \" Pathophysiology of Haemostasis and Thrombosis , vol .", "label": "", "metadata": {}, "score": "53.707"}
{"text": "RESULTS .Baseline Characteristics .In all , 89 HCV / HIV - coinfected patients and 235 HCV - monoinfected controls were included .Recipient , donor , and transplant - related characteristics are shown in Table 1 .", "label": "", "metadata": {}, "score": "53.79541"}
{"text": "In a Spanish study , 45 liver transplant recipients were followed up to three years after transplantation .Before transplantation , severe vitamin D deficiency was present in 62 % of the patients , with a mean serum calcidiol of 9.4 ng / mL. In comparison , 40 healthy age - matched controls displayed a mean serum calcidiol of 23.1 ng / mL. At one year and three years after transplantation , severe vitamin D deficiency was observed in only 14 % and 10 % of the patients , respectively [ 37 ] .", "label": "", "metadata": {}, "score": "53.934856"}
{"text": "Twelve percent of patients across all telaprevir treatment arms discontinued therapy due to skin rash [ 58 ] .A third phase 2 study called PROVE 3 studied 453 genotype 1 chronic HCV patients who had been nonresponders or relapsers to prior therapy with peginterferon and ribavirin [ 59 ] .", "label": "", "metadata": {}, "score": "54.04864"}
{"text": "Kamar et al . have suggested that HCV - positive patients who developed de novo glomerulonephritis have a higher immune response and/or particular cytokine production rather than a direct effect of HCV on kidney cells [ 79 ] .", "label": "", "metadata": {}, "score": "54.07411"}
{"text": "2S , p. 712 , 2008 .View at Google Scholar . E. Akalin , B. Murphy , V. Sehgal , S. Ames , L. Daly , and J. S. Bromberg , \" Rapid steroid withdrawal in hepatitis C virus - positive kidney transplant recipients , \" Clinical Transplantation , vol .", "label": "", "metadata": {}, "score": "54.127388"}
{"text": "They had to have HCV - RNA positive by PCR and no antiviral therapy within the last 12 weeks prior to enrollment in this study .", "label": "", "metadata": {}, "score": "54.251137"}
{"text": "None of the HCV ( ? ) recipients developed HBV infec- tion during the study period ; all three recipients who developed HBV infection were HCV ( ? )", "label": "", "metadata": {}, "score": "54.26072"}
{"text": "777 - 780 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Benci , M. Caremani , D. Menchetti , M. Sasdelli , and P. B. Giusti , \" Low - dose leukocyte interferon- \u03b1 therapy in dialysed patients with chronic hepatitis C , \" Current Medical Research and Opinion , vol .", "label": "", "metadata": {}, "score": "54.35646"}
{"text": "Only one study reported the vitamin D status at the time of cardiac transplantation .Almost 90 % of the patients presented with vitamin D insufficiency and 10 % were found to be severely deficient [ 15 ] .", "label": "", "metadata": {}, "score": "54.46798"}
{"text": "5 , pp .288 - 291 , 1992 .View at Google Scholar .B. J. G. Pereira and A. S. Levey , \" Hepatitis C virus infection in dialysis and renal transplantation , \" Kidney International , vol .", "label": "", "metadata": {}, "score": "54.59196"}
{"text": "We prospectively studied 1011 sera for HCV RNA and HCVcoreAg in a routine real - world setting including 222 samples obtained from patients after liver or kidney transplantation .", "label": "", "metadata": {}, "score": "54.62249"}
{"text": "10 , pp .2433 - 2440 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Casanovas - Taltavull , C. Baliellas , C. Benasco et al . , \" Efficacy of interferon for chronic hepatitis C virus - related hepatitis in kidney transplant candidates on hemodialysis : results after transplantation , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "54.629128"}
{"text": "307 - 314 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. H. Liu , C. C. Liang , C. J. Liu et al . , \" The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C , \" Kidney International , vol .", "label": "", "metadata": {}, "score": "54.652863"}
{"text": "5 , pp .1017 - 1023 , 2001 .View at Google Scholar \u00b7 View at Scopus .C. Hanrotel , O. Toupance , and O. Toupance , \" Virological and histological responses to one year alpha - interferon-2a in hemodialyzed patients with chronic hepatitis C , \" Nephron , vol . 88 , no . 2 , pp .", "label": "", "metadata": {}, "score": "54.70839"}
{"text": "220 - 226 , 2001 .View at Google Scholar \u00b7 View at Scopus . F. Degos , S. Pol , and S. Pol , \" The tolerance and efficacy of interferon- \u03b1 in haemodialysis patients with HCV infection : a multicentre , prospective study , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "54.863953"}
{"text": "J. Heart Lung Transplant .[ Google Scholar ] [ CrossRef ] .Verleden , S.E. ; Vos , R. ; Geenens , R. ; Ruttens , D. ; Vaneylen , A. ; Dupont , L.J. ; Verleden , G.M. ; van Raemdonck , D.E. ; Vanaudenaerde , B.M. Vitamin D deficiency in lung transplant patients : Is it important ?", "label": "", "metadata": {}, "score": "54.874077"}
{"text": "Table 2 .Causes of Graft Loss for HCV / HIV - Coinfected Transplant Recipients and HCV - Monoinfected Transplant Recipients .Rejection [ n ( % ) ] .", "label": "", "metadata": {}, "score": "54.910034"}
{"text": "Stark and colleagues studied the efficacy and safety of hepatitis A vaccine in organ transplant recipients .Study participants were at least 18 years of age , had undergone liver or kidney transplantation and were negative for antibodies to HAV and human immunodeficiency virus .", "label": "", "metadata": {}, "score": "54.93788"}
{"text": "1375 - 1378 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Ortiz , J. Horton , A. Bingaman , et al . , \" Campath 1-H induction and steroid - free maintenance immunosuppression n hepatitis C positive kidney recipients , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "54.948105"}
{"text": "229 - 230 , 1998 .View at Google Scholar .S. Ohta , H. Yokoyama , and H. Yokoyama , \" Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy , \" American Journal of Kidney Diseases , vol .", "label": "", "metadata": {}, "score": "54.96046"}
{"text": "Achieving RNA clearance appeared to be related to the ability to achieve full dosing for at least 3 months preferably for 6 months .Of the 4 patients , for whom data is available so far , able to achieve SVR prior to transplant they remain RNA- after transplant .", "label": "", "metadata": {}, "score": "55.020218"}
{"text": "Abnormal liver function tests were found in 3 patients , one due to fatty liver , one had been treated with steroids for acute rejection , and one treated with leflunomide for BK virus .", "label": "", "metadata": {}, "score": "55.052856"}
{"text": "[ Google Scholar ] [ CrossRef ] .Movassaghi , S. ; Nasiri Toosi , M. ; Bakhshandeh , A. ; Niksolat , F. ; Khazaeipour , Z. ; Tajik , A. Frequency of musculoskeletal complications among the patients receiving solid organ transplantation in a tertiary health - care center .", "label": "", "metadata": {}, "score": "55.160614"}
{"text": "Patients were randomized to one of 3 arms : .A : IFN 2b , 1 million units subq .Daily B : IFN 2b , 3 MU 3x / week C : IFN 2b , 1 MU daily + RBV 400 mg twice daily .", "label": "", "metadata": {}, "score": "55.16249"}
{"text": "357 - 360 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .F. Fabrizi , P. Martin , V. Dixit , S. Bunnapradist , F. Kanwal , and G. Dulai , \" Post - transplant diabetes mellitus and HCV seropositive status after renal transplantation : meta - analysis of clinical studies , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "55.198532"}
{"text": "4 , pp .1170 - 1177 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Espinosa , M. Rodriguez , and M. Rodriguez , \" Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long - term sustained virological and biochemical response , \" Clinical Nephrology , vol .", "label": "", "metadata": {}, "score": "55.206375"}
{"text": "Early detection , prevention , and treatment of complications due to chronic HCV infection can improve the outcomes of HCV - positive kidney transplant recipients .", "label": "", "metadata": {}, "score": "55.232403"}
{"text": "The possibility of reverse zoonotic transmission was experimentally confirmed by the infection of 5 pigs with a patient 's serum .The pigs showed histological inflammation in the liver , and HEV RNA was detectable in different organs , including muscle .", "label": "", "metadata": {}, "score": "55.302853"}
{"text": "21 , pp .1490 - 1495 , 1992 .View at Google Scholar \u00b7 View at Scopus .G. S. Markowitz , J.-T. Cheng , R. B. Colvin , W. M. Trebbin , and V. D. D'Agati , \" Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "55.355606"}
{"text": "The SVR rates of 48 , 47 , and 51 % , respectively , were recorded .The second phase 3 trial , known as ACHIEVE 2/3 , included 932 treatment - na\u00efve patients with genotype 2/3 infection who were randomly assigned to 24 weeks of albinterferon either 900 .", "label": "", "metadata": {}, "score": "55.374687"}
{"text": "Although this is a much higher complication rate than that seen in previous studies , it certainly raises the question about whether or not TJLB should be the method of choice for obtaining liver tissue in patients on hemodialysis .", "label": "", "metadata": {}, "score": "55.521175"}
{"text": "( Phila . )[ Google Scholar ] [ CrossRef ] .Bucharles , S. ; Barberato , S.H. ; Stinghen , A.E. ; Gruber , B. ; Piekala , L. ; Dambiski , A.C. ; Custodio , M.R. ; Pecoits - Filho , R. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism .", "label": "", "metadata": {}, "score": "55.522335"}
{"text": "Several studies have confirmed that patients who achieve an SVR pretransplant while on hemodialysis with either standard IFN or pegylated - IFN ( PEG - IFN ) do not experience reactivation of the virus after kidney transplantation , despite high doses of immunosuppression [ 37 , 38 ] .", "label": "", "metadata": {}, "score": "55.542206"}
{"text": "Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C .Am J Transplant 2006 ; 6 : 2983 - 2993 .", "label": "", "metadata": {}, "score": "55.54487"}
{"text": "HEV antibodies were detected in 1 healthy control ( 1 % ) , 4 patients with chronic liver disease ( 3 % ) , and 10 liver transplant recipients ( 4 % ) .", "label": "", "metadata": {}, "score": "55.686455"}
{"text": "5 , pp .741 - 744 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Baid , M. Pascual , and M. Pascual , \" Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C - positive renal allograft recipients , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "55.708122"}
{"text": "The natural history of HCV in the transplant patient population is difficult to define ; several studies have reported that short - term graft and patient survival are not affected greatly by HCV infection , but long - term ( 10 to 20 years ) survival clearly is worse .", "label": "", "metadata": {}, "score": "55.86486"}
{"text": "Vigilance for rejection and a low threshold for performing biopsy to evaluate abnormal liver tests are recommended .Thus , although there remain many challenges , our results support the continued select use of this lifesaving treatment in HCV / HIV - coinfected patients .", "label": "", "metadata": {}, "score": "56.054626"}
{"text": "4 , pp .372 - 376 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Roccatello , S. Baldovino , D. Rossi et al . , \" Long - term effects of anti - CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "56.057854"}
{"text": "In patients with glomerular filtration rate less than 30 mL / min , the area under the blood concentration - time curve is three times higher than that in patients with normal renal function [ 39 ] .", "label": "", "metadata": {}, "score": "56.11157"}
{"text": "Additionally , in our study , HCV / HIV - coinfected patients had a higher rate of graft loss due to sepsis and multiorgan failure ( although it was not significant ) , and this may have contributed to a survivor bias in the assessment of fibrosis severity .", "label": "", "metadata": {}, "score": "56.127968"}
{"text": "J. Transplant .[ Google Scholar ] .Ewers , B. ; Gasbjerg , A. ; Moelgaard , C. ; Frederiksen , A.M. ; Marckmann , P. Vitamin D status in kidney transplant patients : Need for intensified routine supplementation .", "label": "", "metadata": {}, "score": "56.185898"}
{"text": "In particular , in a randomized controlled trial in kidney transplant recipients , Wissing and colleagues evaluated the effect of 400 mg / day calcium and 25,000 International Units of cholecalciferol per month on bone mineral density one year after transplantation .", "label": "", "metadata": {}, "score": "56.265324"}
{"text": "68 - 77 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. D. Bloom , V. Rao , F. Weng , R. A. Grossman , D. Cohen , and K. C. Mange , \" Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "56.319763"}
{"text": "103 - 109 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .F. Fabrizi , G. Dulai , V. Dixit , S. Bunnapradist , and P. Martin , \" Meta - analysis : interferon for the treatment of chronic hepatitis C in dialysis patients , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "56.347095"}
{"text": "Steroid induction , tapering , and maintenance were performed according to local site practice .The treatment of acute rejection was dictated by local site protocols , and all treated rejection episodes were biopsy - proven .", "label": "", "metadata": {}, "score": "56.40902"}
{"text": "Querings , K. ; Girndt , M. ; Geisel , J. ; Georg , T. ; Tilgen , W. ; Reichrath , J. 25-hydroxyvitamin D deficiency in renal transplant recipients .", "label": "", "metadata": {}, "score": "56.4589"}
{"text": "4 , pp .384 - 389 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. Kamar , K. Sandres - Saun\u00e9 , and L. Rostaing , \" Influence of rituximab therapy on hepatitis C virus RNA concentration in kidney - transplant patients , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "56.46872"}
{"text": "Most studies used a 6-month posttherapy SVR as the end point for successful therapy .Overall , 40 % of treated patients had an SVR , a rate greater than that was usually reported for monotherapy with interferon alfa in patients with hepatitis C without renal disease ( 6 % to 18 % ) .", "label": "", "metadata": {}, "score": "56.557503"}
{"text": "1426 - 1432 , 1998 .View at Publisher \u00b7 View at Google Scholar .O. F. Kokoglu , H. U\u00e7mak , S. Hosoglu et al . , \" Efficacy and tolerability of pegylated - interferon alpha-2a in hemodialysis patients with chronic hepatitis C , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "56.599716"}
{"text": "RESULTS Overall Patient and Graft Survival Seven ( 25 % ) of the 28 recipients died during follow - up .The causes of death were sepsis ( n ? 3 ) , cardiac failure ( n ? 2 ) , recurrent HBV infection ( n ? 1 ) , and recurrent metastatic HCC ( n ?", "label": "", "metadata": {}, "score": "56.605522"}
{"text": "Similarly to the kidney transplant experience , 24 there was no evidence of accelerated HIV disease progression , as indicated by stable or improved CD4 + T cell counts and the control of HIV viremia .", "label": "", "metadata": {}, "score": "56.620018"}
{"text": "11 Ani A. Kardashian , Jennifer C. Price , Hepatitis C virus - HIV - coinfected patients and liver transplantation , Current Opinion in Organ Transplantation , 2015 , 20 , 3 , 276 CrossRef .", "label": "", "metadata": {}, "score": "56.6511"}
{"text": "The SVR rates of 80 , 80 , and 85 percent , respectively , were noted .A dry cough was observed in 40 % of albinterferon - treated patients versus 29 percent in the peginterferon arm .", "label": "", "metadata": {}, "score": "56.662292"}
{"text": "With the shortage of deceased donor organs , increasing numbers of HBcAb ( ? ) liver allografts are being used for liver transplantation ( LTx ) in patients who are HBsAb ( ? )", "label": "", "metadata": {}, "score": "56.712925"}
{"text": "17.5 ng / mL ) [ 45 ] .Even though vitamin D status was reported to improve in the early post - transplant period [ 47 ] , low vitamin D levels are frequently observed in long - term kidney transplant recipients [ 7 , 48 , 49 ] .", "label": "", "metadata": {}, "score": "56.796516"}
{"text": "With low dose , daily dose reduction by 25 % for 4 weeks .Patients are carefully evaluated / monitored throughout the study by assessments including but not limited to liver biopsy , liver tests and clinic visits , alloantibodies , autoantibodies and quantitative immunoglobulin G test results .", "label": "", "metadata": {}, "score": "56.94935"}
{"text": "The author gave a little background and the reasons for his study .Patients with cirrhosis are expanding the waiting list for liver transplantation throughout the world .", "label": "", "metadata": {}, "score": "56.959305"}
{"text": "Actuarial survival was calculated using the Kaplan - Meier formula , and differences in survival for the HCV ( ? ) and HCV ( ? ) groups were compared using the log - rank formula .", "label": "", "metadata": {}, "score": "57.031803"}
{"text": "2887 - 2889 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Casanovas - Taltavull , C. Baliellas , and C. Baliellas , \" Efficacy of interferon for chronic hepatitis C virus - related hepatitis in kidney transplant candidates on hemodialysis : results after transplantation , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "57.074703"}
{"text": "The KDIGO guidelines recommended monthly measurement of liver function test in the first 6 months and then every 3 months thereafter [ 19 ] .Patients with worsening trend in liver enzymes should be referred for Hepatology evaluation .", "label": "", "metadata": {}, "score": "57.079506"}
{"text": "In the untreated control groups , calcidiol either remained stable [ 55 ] , or even decreased further [ 54 ] , over time .Based on their previous study , the group of Courbebaisse established a pharmacokinetic model that describes calcidiol levels after treatment with cholecalciferol in kidney transplant recipients within the first year after transplantation .", "label": "", "metadata": {}, "score": "57.08146"}
{"text": "Even in the long - term post - transplant period , vitamin D deficiency frequently persists .In cardiac transplant recipients with a mean allograft age of approximately four years , more than 90 % of the patients were reported to have hypovitaminosis D , with more than one third of patients displaying severe deficiency [ 18 ] .", "label": "", "metadata": {}, "score": "57.135944"}
{"text": "REFERENCES 1 .Dickson RC , Everhart JE , Lake JR , et al : Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen .", "label": "", "metadata": {}, "score": "57.177673"}
{"text": "Interferon therapy is contraindicated in renal transplant patients due to higher incidence of acute cellular rejection , renal failure , and graft loss [ 46 - 48 ] .", "label": "", "metadata": {}, "score": "57.194775"}
{"text": "Almost 90 % of incident kidney transplant recipients were reported to have insufficient calcidiol levels , with a mean serum calcidiol of 16.6 ng / mL and a trend towards higher calcidiol levels in summer as compared with winter .", "label": "", "metadata": {}, "score": "57.19679"}
{"text": "Moreover , the transjugular approach should be used in patients on peritoneal dialysis .Noninvasive Markers of Fibrosis .Non - invasive markers of fibrosis provide a safe method of determining the presence of advanced liver disease , although predictive values vary and many of the assays have not been validated in ESRD patients .", "label": "", "metadata": {}, "score": "57.249184"}
{"text": "12 , pp .2777 - 2784 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .O. Heisel , R. Heisel , R. Balshaw , and P. Keown , \" New onset diabetes mellitus in patients receiving calcineurin inhibitors : a systematic review and meta - analysis , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "57.330612"}
{"text": "1704 - 1712 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Coco , F. Oliveri , A. M. Maina et al . , \" Transient elastography : a new surrogate marker of liver fibrosis influenced by major changes of transaminases , \" Journal of Viral Hepatitis , vol .", "label": "", "metadata": {}, "score": "57.347713"}
{"text": "Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus .Hepatology 2008 ; 47 : 407 - 417 .", "label": "", "metadata": {}, "score": "57.357437"}
{"text": "Treatment regimens ranged from 4000 International Units daily up to 50,000 International Units daily , with an average treatment period of half a year [ 41 ] .", "label": "", "metadata": {}, "score": "57.376503"}
{"text": "11 - 12 , pp .1071 - 1081 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. W. Russo , R. Ghalib , S. Sigal , and V. Joshi , \" Randomized trial of pegylated interferon \u03b1 -2b monotherapy in haemodialysis patients with chronic hepatitis C , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "57.438686"}
{"text": "Posttransplant characteristics were analyzed as time - dependent covariates .Select antiretrovirals previously linked to liver - related outcomes for nontransplant patients ( PIs , nevirapine , didanosine , and stavudine ) were evaluated as predictors of graft loss in HCV / HIV patients .", "label": "", "metadata": {}, "score": "57.441086"}
{"text": "View at Google Scholar \u00b7 View at Scopus . H. W. Reesink , S. Zeuzem , C. J. Weegink et al . , \" Rapid decline of viral RNA in hepatitis C patients treated with VX-950 : a phase Ib , placebo - controlled , randomized study , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "57.52132"}
{"text": "Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus - coinfected patients : impact of protease inhibitor therapy .Hepatology 2001 ; 34 : 283 - 287 .", "label": "", "metadata": {}, "score": "57.5472"}
{"text": "Several different renal diseases have been reported in HCV - infected patients after kidney transplantation , including recurrent or de novo MPGN , membranous nephropathy , minimal change disease , renal thrombotic microangiopathy , acute transplant glomerulopathy , and chronic transplant glomerulopathy [ 7 , 42 - 45 ] .", "label": "", "metadata": {}, "score": "57.594994"}
{"text": "Transplant .2012 , 26 , E617-E623 .[ Google Scholar ] .Burkhalter , F. ; Schaub , S. ; Dickenmann , M. Preserved circannual rhythm of vitamin D in kidney transplant patients .", "label": "", "metadata": {}, "score": "57.610184"}
{"text": "For HCV - infected patients with chronic kidney disease on maintenance hemodialysis , the 2008 KDIGO guidelines recommend monotherapy with standard interferon that is dose adjusted for a glomerular filtration rate less than 15 mL / min [ 19 ] .", "label": "", "metadata": {}, "score": "57.70694"}
{"text": "J. Kidney Dis .[ Google Scholar ] [ CrossRef ] .Ravani , P. ; Malberti , F. ; Tripepi , G. ; Pecchini , P. ; Cutrupi , S. ; Pizzini , P. ; Mallamaci , F. ; Zoccali , C. Vitamin D levels and patient outcome in chronic kidney disease .", "label": "", "metadata": {}, "score": "57.799503"}
{"text": "21 Donor biopsy data are not available , so it is unknown whether greater severity of disease in anti - HCV - positive donors could account for this difference between HCV / HIV - coinfected recipients and HCV - monoinfected recipients .", "label": "", "metadata": {}, "score": "57.801346"}
{"text": "DEMOGRAPHICS ( half of patients are transplant candidates and 40 % are on waiting list ) .Prior history of alcohol : 50 % .Genotype 1 : 77 % .", "label": "", "metadata": {}, "score": "57.810394"}
{"text": "Wkly .2012 , 142 , w13672 .[ Google Scholar ] .National Kidney Foundation .K / DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease .", "label": "", "metadata": {}, "score": "57.821484"}
{"text": "Patients had to be on the active waiting list at one of these centers with a status 2b ( Child - Pugh class C ) .", "label": "", "metadata": {}, "score": "57.83386"}
{"text": "Although advanced kidney disease has generally been considered a contraindication to ribavirin use , some clinicians prescribe ribavirin in significantly reduced doses to hemodialysis patients ( e.g. , 200 mg three times weekly ) [ 39 , 40 ] .", "label": "", "metadata": {}, "score": "57.841003"}
{"text": "A meta - analysis of multiple clinical studies reported the incidence of NODAT between 7.9 % and 50 % [ 36 ] .Bloom et al . reported a prevalence of 39.4 % in HCV - positive kidney transplant recipients compared to 9.8 % of HCV - negative patients , . )", "label": "", "metadata": {}, "score": "57.891663"}
{"text": "Similar results were obtained when the multivariate analysis was restricted to the first 30 days after transplantation ( data not shown ) .Table 5 .", "label": "", "metadata": {}, "score": "57.89811"}
{"text": "Lung Res .[ Google Scholar ] [ CrossRef ] .Aris , R.M. ; Renner , J.B. ; Winders , A.D. ; Buell , H.E. ; Riggs , D.B. ; Lester , G.E. ; Ontjes , D.A. Increased rate of fractures and severe kyphosis : Sequelae of living into adulthood with cystic fibrosis .", "label": "", "metadata": {}, "score": "57.92456"}
{"text": "3 No HCV - specific selection criteria were used .All patients with hepatocellular carcinoma ( HCC ) were within the Milan criteria .The research protocol was approved and monitored by the institutional review boards of all participating centers and the data and safety monitoring board of the National Institute of Allergy and Infectious Diseases .", "label": "", "metadata": {}, "score": "58.005974"}
{"text": "J. Med .[ Google Scholar ] [ CrossRef ] .Zittermann , A. ; Schleithoff , S.S. ; Gotting , C. ; Dronow , O. ; Fuchs , U. ; Kuhn , J. ; Kleesiek , K. ; Tenderich , G. ; Koerfer , R. Poor outcome in end - stage heart failure patients with low circulating calcitriol levels .", "label": "", "metadata": {}, "score": "58.00686"}
{"text": "Our aim in this study was to assess outcome for HCV ( ? ) and HCV ( ? ) patients who received HBcAb ( ? ) liver grafts from deceased donors and also received a short course of HBIg with long - term lamivudine therapy after LTx .", "label": "", "metadata": {}, "score": "58.02407"}
{"text": "Douglas DD , Rakela J , Wright TL , et al : The clinical course of transplantation - associated de novo hepatitis B infection in the liver transplant recipient .", "label": "", "metadata": {}, "score": "58.026573"}
{"text": "Finally , to minimize errors related to the assessment of liver disease severity , we focused on advanced fibrosis ( bridging fibrosis and cirrhosis ) as the critical endpoint .", "label": "", "metadata": {}, "score": "58.04925"}
{"text": "Full - text \u00b7 Article \u00b7 Jun 2012 \u00b7 Liver international : official journal of the International Association for the Study of the Liver .[ Show abstract ] [ Hide abstract ] ABSTRACT : Cases of chronic or prolonged hepatitis E virus ( HEV ) infections have been described in solid organ transplant recipients , HIV infected patients and in patients with malignancies or idiopathic CD4(+ ) T lymphopenia .", "label": "", "metadata": {}, "score": "58.20188"}
{"text": "In contrast , Courbebaisse and colleagues used 100,000 International Units of cholecalciferol once every two weeks for two months and , thereafter , treated the patients with 100,000 International Units of cholecalciferol every two months for another six months .", "label": "", "metadata": {}, "score": "58.213356"}
{"text": "Liver Int .[ Google Scholar ] [ CrossRef ] .Nessim , S.J. ; Jassal , S.V. ; Fung , S.V. ; Chan , C.T. Conversion from conventional to nocturnal hemodialysis improves vitamin D levels .", "label": "", "metadata": {}, "score": "58.266224"}
{"text": "The degree of responsiveness was greater in the liver transplant recipients , probably because they used fewer immunosuppressive drugs .The authors recommend that transplant recipients who have chronic hepatitis B or C virus infection or who are highly exposed to hepatitis A be given the hepatitis A vaccine .", "label": "", "metadata": {}, "score": "58.27555"}
{"text": "described the association of HCV infection with the development of de novo thrombotic microangiopathy in the renal allograft , especially in patients with pretransplant anticardiolipin antibodies [ 80 ] .", "label": "", "metadata": {}, "score": "58.3018"}
{"text": "While 23 % of status 1 patients displayed severe vitamin D deficiency , only 8 % of status 2 patients did so [ 13 ] .", "label": "", "metadata": {}, "score": "58.387787"}
{"text": "Vitamin D Status in Lung Transplant Recipients .In short - term lung transplant recipients in the United States , the proportion of patients with vitamin D insufficiency decreased from 79 % at the time of transplantation to 26 % at one year post - transplant .", "label": "", "metadata": {}, "score": "58.458405"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Morales , J. Pascual - Capdevila , and J. Pascual - Capdevila , \" Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "58.478638"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. M. Toth , M. Pascual , R. T. Chung , F. Graeme - Cook , J. L. Dienstag , A. K. Bhan , and A. B. Cosimi , \" Hepatitis C virus - associated fibrosing cholestatic hepatitis after renal transplantation : response to interferon - alpha therapy , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "58.522896"}
{"text": "[ Google Scholar ] [ CrossRef ] .Abbott - Johnson , W.J. ; Kerlin , P. ; Abiad , G. ; Clague , A.E. ; Cuneo , R.C. Dark adaptation in vitamin A - deficient adults awaiting liver transplantation : Improvement with intramuscular vitamin A treatment .", "label": "", "metadata": {}, "score": "58.52348"}
{"text": "Four weeks after the second dose was given , the rates of response rose to 97 , 72 and 100 percent , respectively .The results were similar between the liver transplant recipient and control groups in regard to mean antibody titers ; however , mean antibody titers were significantly lower among the renal transplant recipients .", "label": "", "metadata": {}, "score": "58.65155"}
{"text": "[ 57 ] .SVR was achieved in 69 and 60 percent of patients in the 24 and 12 week arms , respectively , while the SVR was 46 percent in the standard of care 48 week arm .", "label": "", "metadata": {}, "score": "58.654293"}
{"text": "Polymerase chain reaction identified 16 of the patients as HCV - RNA ( ? ) and 12 as HCV - RNA ( ? )All recipients were followed until November 2004 ( mean follow - up period 36.4 ? 19.0 months ) .", "label": "", "metadata": {}, "score": "58.6914"}
{"text": "10 , pp .1896 - 1902 , 2000 .View at Google Scholar \u00b7 View at Scopus .B. J. G. Pereira , S. N. Natov , and S. N. Natov , \" Effect of hepatitis C infection and renal transplantation on survival in end - stage renal disease .", "label": "", "metadata": {}, "score": "58.736786"}
{"text": "Heart transplant recipients and patients undergoing cardiac surgery have an increased risk for HEV infections .Chronic hepatitis E may explain elevated liver enzymes in heart transplant recipients .", "label": "", "metadata": {}, "score": "58.789062"}
{"text": "Acute Rejection .Twenty - five of the 28 coinfected subjects who experienced rejection were on antiretroviral therapy at the time of first - treated acute rejection .", "label": "", "metadata": {}, "score": "58.877647"}
{"text": "255 - 261 , 2000 .View at Google Scholar \u00b7 View at Scopus . E. Zuckerman , D. Keren , and D. Keren , \" Treatment of refractory symptomatic , hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon- \u03b1 , \" Journal of Rheumatology , vol .", "label": "", "metadata": {}, "score": "58.909927"}
{"text": "260A. View at Google Scholar .B. J. G. Pereira , S. N. Natov , and S. N. Natov , \" Effect of hepatitis C infection and renal transplantation on survival in end - stage renal disease .", "label": "", "metadata": {}, "score": "58.936592"}
{"text": "Management of the Kidney Transplant Patient with Chronic Hepatitis C Infection .Received 2 December 2010 ; Accepted 25 January 2011 .Academic Editor : James E. Springate .", "label": "", "metadata": {}, "score": "58.95778"}
{"text": "However , a regimen of three million units of IFN \u03b1 -2b given subcutaneously three times per week or PEG - IFN \u03b1 -2a 135 mcg weekly for 6 to 12 months appears to be safe and effective in inducing an SVR [ 39 ] .", "label": "", "metadata": {}, "score": "58.97416"}
{"text": "One month after transplant the VL was 8.41 million .ADVERSE EVENTS .The author said the take home message from this study was that there were a large number of adverse events , and this was the major concern .", "label": "", "metadata": {}, "score": "59.021675"}
{"text": "However , there are no definitive data for its use in renal transplant patients for this indication .Regardless , plasma exchange is extensively and safely used for other indications in this population .", "label": "", "metadata": {}, "score": "59.05332"}
{"text": "Hence , the benefits and risks of receiving HCV - positive donor kidneys should be discussed and explained with the potential renal transplant candidate so that a well informed decision can be made [ 19 ] .", "label": "", "metadata": {}, "score": "59.1262"}
{"text": "Patients with acute hepatitis C also are likely to be suitable candidates for treatment .Finally , persistence of HCV RNA despite interferon monotherapy for 8 to 12 weeks should lead to early discontinuation because the chance of an SVR is highly unlikely [ 40 , 41 ] .", "label": "", "metadata": {}, "score": "59.17697"}
{"text": "4 , pp .525 - 530 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. M. Alavian and S. V. Tabatabaei , \" Meta - analysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection , \" Iranian Journal of Kidney Diseases , vol .", "label": "", "metadata": {}, "score": "59.221184"}
{"text": "The rates of graft survival were calculated on the basis of graft failure for any cause .( C , D ) Kaplan - Meier estimates of patient and graft survival for HCV / HIV - coinfected LT recipients by risk groups .", "label": "", "metadata": {}, "score": "59.256798"}
{"text": "For the management of liver transplant patients , the American Association for the Study of Liver Disease and the American Society of Transplantation released a practice guideline , which recommends calcidiol levels to be maintained above 30 ng / mL for optimal bone health .", "label": "", "metadata": {}, "score": "59.263596"}
{"text": "J. Transplant .2009 , 9 ( Suppl .Wissing , K.M. ; Broeders , N. ; Moreno - Reyes , R. ; Gervy , C. ; Stallenberg , B. ; Abramowicz , D. A controlled study of vitamin D3 to prevent bone loss in renal - transplant patients receiving low doses of steroids .", "label": "", "metadata": {}, "score": "59.3041"}
{"text": "Several clinical trials are currently ongoing with different treatment regimens ( [ 57 ] , NCT00752401 , NCT00748618 , NCT01431430 ) , which will help to identify strategies to maintain optimal vitamin D status .", "label": "", "metadata": {}, "score": "59.391106"}
{"text": "3 , no .5 , pp .680 - 683 , 2002 .View at Google Scholar \u00b7 View at Scopus .C.-C. Lin , L.-T. Yeh , D. Vitarella , and Z. Hong , \" Viramidine , a prodrug of ribavirin , shows better liver - targeting properties and safety profiles than ribavirin in animals , \" Antiviral Chemistry and Chemotherapy , vol .", "label": "", "metadata": {}, "score": "59.442066"}
{"text": "19 Jose M. Miro , Peter Stock , Elina Teicher , Jean - Charles Duclos - Vall\u00e9e , Norah Terrault , Antoni Rimola , Outcome and management of HCV / HIV coinfection pre- and post - liver transplantation .", "label": "", "metadata": {}, "score": "59.459446"}
{"text": "This is a preliminary pilot study , but they saw 33 % of patients ( 25/75 ) , particularly for genotype 2/3 patients .For genotype 1 patients , it 's important to achieve full dosing to clear RNA for at least 3 months .", "label": "", "metadata": {}, "score": "59.460114"}
{"text": "Transplant .[ Google Scholar ] .Tripathi , S.S. ; Gibney , E.M. ; Gehr , T.W. ; King , A.L. ; Beckman , M.J. High prevalence of vitamin D deficiency in African American kidney transplant recipients .", "label": "", "metadata": {}, "score": "59.48168"}
{"text": "A phase II trial randomly assigned 90 treatment - na\u00efve patients to one of five different regimens for 29 days : peginterferon monotherapy , peginterferon plus Debio-025 at three different doses , and Debio-025 monotherapy [ 64 ] .", "label": "", "metadata": {}, "score": "59.53356"}
{"text": "184 - 192 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. A. Shahin , S. M. El Desouky , and H. S. Zayed , \" A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide , \" Clinical Rheumatology .", "label": "", "metadata": {}, "score": "59.597412"}
{"text": "In patients with native kidney cryoglobulinemic glomerulonephritis , plasma exchange three times a week for 2 to 3 weeks has been successfully used [ 85 ] .", "label": "", "metadata": {}, "score": "59.63856"}
{"text": "181 - 194 , 2010 .View at Google Scholar .F. Fabrizi , V. Dixit , P. Martin , and P. Messa , \" Combined antiviral therapy of hepatitis C virus in dialysis patients : meta - analysis of clinical trials , \" The Journal of Viral Hepatitis .", "label": "", "metadata": {}, "score": "59.68668"}
{"text": "Our results indicate that a short course of HBIg- lamivudine combination therapy provides effective pro- phylaxis against HBV infection in 89 % of recipients of HBcAb ( ? ) grafts .", "label": "", "metadata": {}, "score": "59.79079"}
{"text": "Clinical cirrhosis : 24 % .Non - cirrhosis but had bridging fibrosis : 14 % .63 % had one or more of these complications : .", "label": "", "metadata": {}, "score": "59.858944"}
{"text": "With the introduction of routine screening and heightened attention to prevention of spread , the incidence of HCV infection has declined in dialysis centers in many countries , but remained high in others [ 18 ] .", "label": "", "metadata": {}, "score": "59.908016"}
{"text": "Figure 1 .( A ) Kaplan - Meier estimates of patient survival for HCV / HIV - coinfected recipients and HCV - monoinfected LT recipients .", "label": "", "metadata": {}, "score": "59.923874"}
{"text": "Dodson SF , Bonham CA , Geller DA , et al : Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti - HBc positive donors .", "label": "", "metadata": {}, "score": "59.946686"}
{"text": "This study compares the graft / patient survival from standard ( SD ) and ECD for our transplant population between 2001 and 2005 .Outcomes included graft and patient survival at 90 days , 1 year , and 2 years .", "label": "", "metadata": {}, "score": "60.035027"}
{"text": "Initial therapy : IFN-2b 1.5 MU tiw + Ribivarin 600 mg / day .After 2 weeks they tried to increase IFN dose to 3 MU tiw ( full dose ) , if therapy was tolerable and WBC and platelet count were stable .", "label": "", "metadata": {}, "score": "60.038185"}
{"text": "In 1981 , we were the first in the Midwest to perform a combined liver - kidney transplant .In 1990 , we performed a liver - pancreas transplant , and in 1996 , we performed the first combined liver - intestine transplant .", "label": "", "metadata": {}, "score": "60.119"}
{"text": "Impact of human immunodeficiency virus on survival after liver transplantation : analysis of United Network for Organ Sharing database .Transplantation 2008 ; 85 : 359 - 368 .", "label": "", "metadata": {}, "score": "60.161057"}
{"text": "The management of kidney transplant recipients with chronic HCV infection is complex .Evaluation of HCV - Positive Renal Transplant Candidates .All patients undergoing a renal transplant evaluation should be screened for chronic HCV infection with a third generation anti - HCV enzyme - linked immunoassay .", "label": "", "metadata": {}, "score": "60.177044"}
{"text": "The use of OKT3 and polyclonal anti - lymphocyte preparations was restricted to patients with severe rejection .Follow - Up in the HCV - Monoinfected Control Group .", "label": "", "metadata": {}, "score": "60.232906"}
{"text": "12 , pp .3054 - 3061 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Iyoda , K. L. Hudkins , S. Becker - Herman et al . , \" Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "60.25979"}
{"text": "J. Izopet , L. Rostaing , and L. Rostaing , \" High rate of hepatitis C virus clearance in hemodialysis patients after interferon-\u03b1 therapy , \" Journal of Infectious Diseases , vol .", "label": "", "metadata": {}, "score": "60.322784"}
{"text": "Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus - positive hemophiliacs and should be treated as an opportunistic infection .J Infect Dis 1999 ; 179 : 1254 - 1258 .", "label": "", "metadata": {}, "score": "60.46666"}
{"text": "c289-c295 , 2010 .View at Publisher \u00b7 View at Google Scholar .V. S. Kamanna , M. L. Kashyap , R. Pai et al . , \" Uremic serum subfraction inhibits apolipoprotein A - I production by a human hepatoma cell line , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "60.519585"}
{"text": "Patients were eligible if they or their parents were not born in Germany .Serological screening for hepatitis B core protein antibodies , hepatitis B surface antigens ( HBsAgs ) , and anti - hepatitis C virus antibodies was performed in each individual . HBsAg - positive and anti - hepatitis C virus - positive patients were further tested for molecular markers of viral replication .", "label": "", "metadata": {}, "score": "60.53057"}
{"text": "View at Google Scholar .V. Agnello , R. T. Chung , and L. M. Kaplan , \" A role for hepatitis C virus infection in type II cryoglobulinemia , \" New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "60.566628"}
{"text": "Kaplan - Meier survival analysis failed to demonstrate an overall difference in graft or patient survival at any time point .Liver grafts from ECD can be used to dramatically reduce wait list time with outcomes comparable to those for SD without resorting to living donor liver transplantation .", "label": "", "metadata": {}, "score": "60.575073"}
{"text": "The 48- and 24-week no lead - in groups had SVR rates of 67 and 54 percent , respectively .In part 2 of SPRINT-1 , the \" low - dose \" ribavirin group had an SVR of only 36 percent compared to 50 percent for the \" full - dose \" ribavirin group .", "label": "", "metadata": {}, "score": "60.584187"}
{"text": "HBsAgs were found in 3.6 % of patients .Overall , hepatitis B virus DNA was detected in 2.2 % of patients .Markers for hepatitis C virus infection were found in an almost similar high frequency ( 1.9 % ) .", "label": "", "metadata": {}, "score": "60.678814"}
{"text": "The mean antibody titers were 1,340 mIU per mL for monotherapy , 136 mIU per mL for double therapy and 88 mIU per mL for triple therapy .", "label": "", "metadata": {}, "score": "60.687958"}
{"text": "Screening for proteinuria should be done every 3 - 6 months for the first year and every 6 months thereafter .The kidney biopsy should be studied with light microscopy , immunofluorescence techniques and electron microscopy .", "label": "", "metadata": {}, "score": "60.713074"}
{"text": "Intern .Med .[ Google Scholar ] [ CrossRef ] .Arteh , J. ; Narra , S. ; Nair , S. Prevalence of vitamin D deficiency in chronic liver disease .", "label": "", "metadata": {}, "score": "60.719307"}
{"text": "1254 - 1258 , 1998 .View at Google Scholar \u00b7 View at Scopus .V. G. Bain , K. D. Kaita , and K. D. Kaita , \" A phase 2 study to evaluate the antiviral activity , safety , and pharmacokinetics of recombinant human albumin - interferon alfa fusion protein in genotype 1 chronic hepatitis C patients , \" Journal of Hepatology , vol .", "label": "", "metadata": {}, "score": "60.75451"}
{"text": "[ Google Scholar ] [ CrossRef ] .Miroliaee , A. ; Nasiri - Toosi , M. ; Khalilzadeh , O. ; Esteghamati , A. ; Abdollahi , A. ; Mazloumi , M. Disturbances of parathyroid hormone - vitamin D axis in non - cholestatic chronic liver disease : A cross - sectional study .", "label": "", "metadata": {}, "score": "60.78971"}
{"text": "We studied a cohort of 73 CVID patients recruited in a low endemic Central European country .None of the subjects tested positive for HEV RNA or anti - HEV IgG. To verify that such pooled blood products contain anti - HEV protective antibodies we measured the anti - HEV IgG optical density ( OD ) values in patients before and after transfusion .", "label": "", "metadata": {}, "score": "60.82004"}
{"text": "He advises and received grants from Merck , Vertex , Boehringer Ingleheim , and SciClone .Abstract .Hepatitis C virus ( HCV ) is a controversial indication for liver transplantation ( LT ) in human immunodeficiency virus ( HIV)-infected patients because of reportedly poor outcomes .", "label": "", "metadata": {}, "score": "60.868885"}
{"text": "Please refer to this study by its ClinicalTrials.gov identifier : NCT00320606 With the shortage of donor organs , increasing number of hepatitis B core antibody ( HBcAb)-positive [ HBcAb(+ ) ] liver allografts are being used for liver transplantation ( LTx ) in patients who are HBcab - negative [ HBsAb(-)].", "label": "", "metadata": {}, "score": "60.881668"}
{"text": "Other / unknown [ n ( % ) ] .Table 3 .Predictors of Death and Graft Loss in HIV / HCV - Coinfected Transplant Recipients and HCV - Monoinfected Transplant Recipients .", "label": "", "metadata": {}, "score": "60.907288"}
{"text": "2092 - 2098 , 2003 .View at Google Scholar . H. Weclawiak , N. Kamar , A. Ould - Mohamed , et al . , \" Treatment of chronic hepatitis C virus infection in dialysis patients : an update , \" Hepatitis Research and Treatment , vol .", "label": "", "metadata": {}, "score": "60.916855"}
{"text": "Serious complications occurred in 8 % .I think Everson said he would expect this rate of complications in this population anyway .G - CSF required in 28 % and Epo in 1 % .", "label": "", "metadata": {}, "score": "61.191765"}
{"text": "( n ?Four ( 33.3 % ) of the HCV ( ? ) patients died at 7.5 , 7.7 , 19.1 , and 23.2 months posttransplantation .", "label": "", "metadata": {}, "score": "61.21114"}
{"text": "In order to prevent the rejection of transplanted organs , transplant recipients are prescribed a strict , lifelong regimen of immunosuppressive drugs .While these drugs help prevent the body from rejecting the transplant , they carry numerous complications , including increased risk of serious infections and certain types of cancer .", "label": "", "metadata": {}, "score": "61.259212"}
{"text": "J. Ophthalmol .[ Google Scholar ] [ CrossRef ] .Reese , P.P. ; Bloom , R.D. ; Feldman , H.I. ; Huverserian , A. ; Thomasson , A. ; Shults , J. ; Hamano , T. ; Goral , S. ; Shaked , A. ; Olthoff , K. ; et al .", "label": "", "metadata": {}, "score": "61.30745"}
{"text": "In addition , we compared the clinical long - term outcome of HBeAg - positive HDV - infected patients with HBeAg - negative control patients matched for age , gender and baseline - MELD score .", "label": "", "metadata": {}, "score": "61.315647"}
{"text": "The FibroTest is not currently recommended as an alternative to liver biopsy in renal transplant candidates .These results were confirmed in a recent prospective analysis that found the APRI to be an accurate and reproducible method of measuring significant fibrosis in hemodialysis patients with chronic HCV [ 31 ] .", "label": "", "metadata": {}, "score": "61.39177"}
{"text": "Meems , L.M. ; van der Harst , P. ; van Gilst , W.H. ; de Boer , R.A. Vitamin D biology in heart failure : Molecular mechanisms and systematic review .", "label": "", "metadata": {}, "score": "61.393982"}
{"text": "Gastroenterol .Hepatol .[ Google Scholar ] [ CrossRef ] .Bitetto , D. ; Fabris , C. ; Falleti , E. ; Fornasiere , E. ; Fumolo , E. ; Fontanini , E. ; Cussigh , A. ; Occhino , G. ; Baccarani , U. ; Pirisi , M. ; et al .", "label": "", "metadata": {}, "score": "61.39553"}
{"text": "Therefore , the aim of this study was to perform large - scale screening for hepatitis markers in primary care centres treating mainly individuals with a migrational background in Germany .", "label": "", "metadata": {}, "score": "61.425488"}
{"text": "362 , p. 1647 , 2010 .View at Google Scholar .48 , p. 1024A , 2008 .View at Google Scholar .B. E. Korba , A. B. Montero , K. Farrar , K. Gaye , S. Mukerjee , M. S. Ayers , and J.-F. Rossignol , \" Nitazoxanide , tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication , \" Antiviral Research , vol .", "label": "", "metadata": {}, "score": "61.442883"}
{"text": "J. Kidney Dis .2003 , 42 , S1-S201 .KDIGO .KDIGO clinical practice guideline for the care of kidney transplant recipients .", "label": "", "metadata": {}, "score": "61.447468"}
{"text": "Treatment with vitamin D supplements is recommended in osteopenic liver transplant recipients with a Level of Evidence A [ 40 ] .Chronic Kidney Disease and Kidney Transplantation .", "label": "", "metadata": {}, "score": "61.502235"}
{"text": "J. Clin .Endocrinol .Metab .[ Google Scholar ] [ CrossRef ] .Shane , E. ; Mancini , D. ; Aaronson , K. ; Silverberg , S.J. ; Seibel , M.J. ; Addesso , V. ; McMahon , D.J. Bone mass , vitamin D deficiency , and hyperparathyroidism in congestive heart failure .", "label": "", "metadata": {}, "score": "61.552437"}
{"text": "Staff should be designated to review results regularly , and a plan should be developed to investigate new cases .Therapy of Hepatitis C in Dialysis Patients .", "label": "", "metadata": {}, "score": "61.559082"}
{"text": "The safety and efficacy of Campath-1 induction and a steroid - free maintenance regimen with tacrolimus and mycophenolate were evaluated in 24 HCV - positive kidney transplant recipients [ 63 ] .", "label": "", "metadata": {}, "score": "61.56009"}
{"text": "Lost , Transplantation , 2015 , 99 , 9 , 1744 CrossRef .2 I. Campos - Varela , M. G. Peters , N. A. Terrault , Advances in Therapy for HIV / Hepatitis C Virus - Coinfected Patients in the Liver Transplant Setting , Clinical Infectious Diseases , 2015 , 60 , 1 , 108 CrossRef .", "label": "", "metadata": {}, "score": "61.736053"}
{"text": "4 , pp .981 - 999 , 1997 .View at Google Scholar \u00b7 View at Scopus .US Renal Data System : USRDS 2002 Annual Data Report , The National Institutes of Health , National Institute of Diabetes and Digestive and Kidney Diseases , Bethesda , Md , USA , 2002 . E. Nakayama , T. Akiba , F. Marumo , and C. Sato , \" Prognosis of anti - hepatitis C virus antibody - positive patients on regular hemodialysis therapy , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "61.75527"}
{"text": "Estimates of stiffness of the liver by ultrasound correlate with fibrosis stage [ 71 ] .All patients with low Fibroscan scores ( . ; 11 kPa ) showed a severe form of liver fibrosis with clinical evidence of portal hypertension [ 72 ] .", "label": "", "metadata": {}, "score": "61.888996"}
{"text": "Dis .Sci .[ Google Scholar ] [ CrossRef ] .Malham , M. ; Jorgensen , S.P. ; Ott , P. ; Agnholt , J. ; Vilstrup , H. ; Borre , M. ; Dahlerup , J.F. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology .", "label": "", "metadata": {}, "score": "61.892433"}
{"text": "Cirrhosis has a prevalence of approximately 10 % in ESRD patients with chronic HCV infection [ 17 ] .The presence of cirrhosis is usually considered to be a contraindication to renal transplantation , but these patients can be considered for combined liver - kidney transplantation , if there is evidence of decompensated liver disease and portal hypertension .", "label": "", "metadata": {}, "score": "61.908623"}
{"text": "Severity and correlates of liver disease in hepatitis C virus - infected injection drug users .Hepatology 2002 ; 35 : 1247 - 1255 .10 Thein HH , Yi Q , Dore GJ , Krahn MD .", "label": "", "metadata": {}, "score": "61.938824"}
{"text": "16 Coilly Audrey , Bruno Raffaele , Liver transplantation for hepatitis C virus in the era of direct - acting antiviral agents , Current Opinion in HIV and AIDS , 2015 , 10 , 5 , 361 CrossRef .", "label": "", "metadata": {}, "score": "61.958412"}
{"text": "A NS3/4A protease inhibitor in humans has been vigorously studied and is currently in phase III clinical trials .In PROVE 1 , a total of 263 patients were randomly assigned to one of three telaprevir groups or to a control group .", "label": "", "metadata": {}, "score": "62.030704"}
{"text": "Notably , in one study , more than one fifth of the patients had serum calcidiol below the detection limit of 6.8 ng / mL [ 15 ] .", "label": "", "metadata": {}, "score": "62.12326"}
{"text": "J. Heart Fail .[ Google Scholar ] .Stein , E.M. ; Cohen , A. ; Freeby , M. ; Rogers , H. ; Kokolus , S. ; Scott , V. ; Mancini , D. ; Restaino , S. ; Brown , R. ; McMahon , D.J. ; et al .", "label": "", "metadata": {}, "score": "62.14515"}
{"text": "Evaluating HCV after Kidney Transplantation .The natural history of HCV - related liver disease in kidney transplant recipients is controversial ; however , there are some data to suggest that progression rate to cirrhosis may be slower in HCV - positive renal transplant recipients compared to HCV - positive controls without kidney disease [ 68 ] .", "label": "", "metadata": {}, "score": "62.251266"}
{"text": "None of the urgent or high urgent and only about 5 % of the elective transplant candidates had sufficient vitamin D levels .Severe vitamin D deficiency was present in 57 % of urgent or high urgent and in 50 % of elective transplant candidates [ 14 ] .", "label": "", "metadata": {}, "score": "62.2589"}
{"text": "One of them has been the introduction of living donor liver transplantation .In this review , we will focus on the current use of allografts from donors with antihepatitis B core antibody and/or antibodies against hepatitis C virus in cadaveric and living donor liver transplantation .", "label": "", "metadata": {}, "score": "62.269226"}
{"text": "The primary study endpoints were patient and graft survival .Secondary endpoints included the rate of severe HCV disease ( defined by the presence of cholestatic hepatitis or bridging fibrosis / cirrhosis or by graft loss due to HCV ) and the rate of treated acute rejection .", "label": "", "metadata": {}, "score": "62.281124"}
{"text": "High risk were HBV na\u00efve recipients , moderate risk recipients had isolated hepatitis B surface antibody ( anti - HBs ) or hepatitis B core antibody ( anti - HBc ) , while low - risk recipients had both anti - HBs and anti - HBc .", "label": "", "metadata": {}, "score": "62.300888"}
{"text": "Achievement of sustained virological response ( SVR ) with treatment of HCV not only can prevent progression of liver disease but also reduce the development of posttransplant complications , including HCV - associated nephropathy [ 35 ] and new onset diabetes mellitus [ 36 ] .", "label": "", "metadata": {}, "score": "62.311237"}
{"text": "Likewise , the proportional distribution of patients with vitamin D insufficiency and severe deficiency was similar [ 44 ] .Vitamin D Status in Kidney Transplant Recipients .", "label": "", "metadata": {}, "score": "62.39019"}
{"text": "Only 1 patient ( 1.3 % ) with ESRD developed a moderate complication , compared with a 2.1 % complication rate in the control group , with 3 of them having a severe complication .", "label": "", "metadata": {}, "score": "62.418983"}
{"text": "Use of HCV Antibody - Positive Donor Kidneys .While it is well accepted that kidneys from HCV - positive donors should not be transplanted into HCV - negative recipients , the use of kidneys from HCV - infected donors for transplant in HCV - positive recipients has been controversial [ 1 , 18 , 19 ] .", "label": "", "metadata": {}, "score": "62.42561"}
{"text": "View at Publisher \u00b7 View at Google Scholar .S. N. Natov , J. Y. Lau , R. Ruthazer , et al . , \" hepatitis C virus genotype does not affect patient survival among renal transplant candidates .", "label": "", "metadata": {}, "score": "62.46161"}
{"text": "So , there are two main reasons to potentially treat patients with decompensated cirrhosis .If patients can clear HCV RNA they may improve or stabilize liver function and maybe they can come off transplant list .", "label": "", "metadata": {}, "score": "62.52115"}
{"text": "One AIH patient receiving immunosuppression with cyclosporin and prednisolone and elevated ALT levels had acute hepatitis E but HEV viremia resolved after reducing immunosuppressive medication .", "label": "", "metadata": {}, "score": "62.559364"}
{"text": "Horm .[ Google Scholar ] [ CrossRef ] .Bock , G. ; Prietl , B. ; Mader , J.K. ; Holler , E. ; Wolf , M. ; Pilz , S. ; Graninger , W.B. ; Obermayer - Pietsch , B.M. ; Pieber , T.R. The effect of vitamin D supplementation on peripheral regulatory T cells and beta cell function in healthy humans : A randomized controlled trial .", "label": "", "metadata": {}, "score": "62.597473"}
{"text": "The purpose of the study was to determine whether pretransplant antiviral therapy is practical by studying the tolerability and efficacy of interferon a2b ( IFN ) with or without ribivarin ( RBV ) , in patients with decompensated hepatitis C awaiting transplants .", "label": "", "metadata": {}, "score": "62.652733"}
{"text": "J. Clin .Nutr .[ Google Scholar ] .Penny , H. ; Frame , S. ; Dickinson , F. ; Garrett , G. ; Young , A.R. ; Sarkany , R. ; Chitalia , N. ; Hampson , G. ; Goldsmith , D. Determinants of vitamin D status in long - term renal transplant patients .", "label": "", "metadata": {}, "score": "62.653343"}
{"text": "Al - Sebayel MI , Khalaf HA , Ramirez CG : The prevalence of hepatitis B core antibody positivity in donors for liver transplanta- tion in Saudi Arabia .", "label": "", "metadata": {}, "score": "62.682785"}
{"text": "Everson reported clearance rates in several ways : . all patients ( intent - to - treat ) 25/86- 29 % .enrolled patients 25/75- 33 % .", "label": "", "metadata": {}, "score": "62.70909"}
{"text": "Third , cytomegalovirus infection was strongly associated with graft loss , and we recommend the use of universal prophylaxis to minimize any risk for this complication .", "label": "", "metadata": {}, "score": "62.7133"}
{"text": "Alternatively , it is also possible that the higher rates of acute rejection in patients with HIV reflect an inherently enhanced immune response and dysregulation of the immune response .", "label": "", "metadata": {}, "score": "62.74486"}
{"text": "In these studies , the frequency of bridging hepatic fibrosis ( stage 3 ) or cirrhosis ( stage 4 ) ranged from 5 % to 32 % .", "label": "", "metadata": {}, "score": "62.792553"}
{"text": "Pre - transplant use of IFN - based therapies for treatment of HCV infection may prevent the development of post - transplant glomerulonephritis .Antiviral therapies such as ribavirin can be used in kidney transplant recipients with HCV - associated glomerulopathy [ 83 ] .", "label": "", "metadata": {}, "score": "62.80011"}
{"text": "All recipients received a short course of HBIg prophylaxis ( 10,000 units / day for 4 days ) and long - term lamivudine 100 mg / d after LTx in addition to a tacrolimus - based immunosuppressive regimen .", "label": "", "metadata": {}, "score": "62.82007"}
{"text": "Dodson SF : Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors .Clin Transplant 14(suppl 2):20 , 2000 8 .", "label": "", "metadata": {}, "score": "62.828667"}
{"text": "CHARACTERISTICS of RESPONDERS .Everson stressed two points : The statistically significant ability to respond for genotype 1 ; and the response capacity based upon reaching full dose ( see table below ) .", "label": "", "metadata": {}, "score": "62.949875"}
{"text": "J. Bone Miner .Res .[ Google Scholar ] .Nutr .Metab ( Lond . )[ Google Scholar ] .Alvarez , J.A. ; Zughaier , S.M. ; Law , J. ; Hao , L. ; Wasse , H. ; Ziegler , T.R. ; Tangpricha , V. Effects of high - dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease .", "label": "", "metadata": {}, "score": "62.964264"}
{"text": "Posttransplant Management of HCV - Positive Renal Transplants .As there is increased risk of development of glomerulopathy and graft loss in HCV - positive patients , close monitoring for the development of proteinuria is required .", "label": "", "metadata": {}, "score": "63.045147"}
{"text": "Bloom et al . reported that 57.8 % of HCV - positive patients treated with tacrolimus developed NODAT compared with 7.7 % on cyclosporine therapy ( .", "label": "", "metadata": {}, "score": "63.092846"}
{"text": "Correlation of HCVcoreAg with HCV RNA was studied cross - sectionally in HIV / HCV- and HBV / HCV - coinfected patients , as well as before and after hemodialysis in patients with end - stage renal disease .", "label": "", "metadata": {}, "score": "63.11435"}
{"text": "In the United States , the rate of HCV infection in hemodialysis patients has declined from 10.4 % in 1995 to 7.8 % in 2002 [ 5 ] , compared to the 1.8 % prevalence observed in the general population [ 6 ] .", "label": "", "metadata": {}, "score": "63.136955"}
{"text": "Am J Transplant 2005 ; 5 : 549 - 557 .21Northup PG , Argo CK , Nguyen DT , McBride MA , Kumer SC , Schmitt TM , Pruett TL .", "label": "", "metadata": {}, "score": "63.161354"}
{"text": "The spectrum of liver disease in HCV positive HD patients has been reported to be mild to moderate [ 22 - 25 ] in most series , and a high proportion of patients had normal ALT levels .", "label": "", "metadata": {}, "score": "63.23472"}
{"text": "In three patients ribavirin treatment was successful with a sustained biochemical and virological response while treatment failed in one cirrhotic patient after ribavirin dose reduction .", "label": "", "metadata": {}, "score": "63.343117"}
{"text": "Without prophylaxis , the reported infection rates are higher than Fig 1 . cAb ( ? ) donor transplants .( A ) Overall patient and graft survival .", "label": "", "metadata": {}, "score": "63.482048"}
{"text": "Details on the vitamin D status in patients with end - stage pulmonary disease and lung transplant recipients are summarized in Table 2 .Interventional Studies and Guidelines .", "label": "", "metadata": {}, "score": "63.52652"}
{"text": "View at Publisher \u00b7 View at Google Scholar .T. Namba , R. Shiba , T. Yamamoto et al . , \" Successful treatment of HCV - related cryoglobulinemic glomerulonephritis with double - filtration plasmapheresis and interferon combination therapy , \" Clinical and Experimental Nephrology , vol .", "label": "", "metadata": {}, "score": "63.532852"}
{"text": "In one study ACHIEVE 1 , 1323 treatment - na\u00efve patients with genotype 1 infection were randomized to receive either albinterferon at a dose of 900 .", "label": "", "metadata": {}, "score": "63.573906"}
{"text": "Endocrinol .Metab .[ Google Scholar ] .Liver Transpl .[ Google Scholar ] .LaClair , R.E. ; Hellman , R.N. ; Karp , S.L. ; Kraus , M. ; Ofner , S. ; Li , Q. ; Graves , K.L. ; Moe , S.M. Prevalence of calcidiol deficiency in CKD : A cross - sectional study across latitudes in the United States .", "label": "", "metadata": {}, "score": "63.612152"}
{"text": "The HIV protease inhibitors , however , are hepatically cleared , and appear to be safe in patients with chronic renal failure , as well as for those on hemodialysis [ 56 , 57 ] .", "label": "", "metadata": {}, "score": "63.656326"}
{"text": "Clin .Transplant .[ Google Scholar ] .Forli , L. ; Bollerslev , J. ; Simonsen , S. ; Isaksen , G.A. ; Kvamsdal , K.E. ; Godang , K. ; Gadeholt , G. ; Pripp , A.H. ; Bjortuft , O. Dietary vitamin K2 supplement improves bone status after lung and heart transplantation .", "label": "", "metadata": {}, "score": "63.688225"}
{"text": "The high prevalence of HCV in dialysis patients is of great concern in view of studies that suggest that these patients have a higher mortality than HCV - negative patients [ 20 , 21 ] .", "label": "", "metadata": {}, "score": "63.713253"}
{"text": "Overall , only 52 % of the Architect borderline samples gave similar results in all four assays .Inter - assay concordance ranged between 58 % and 80 % .", "label": "", "metadata": {}, "score": "63.75006"}
{"text": "Am J Transplant 2007 ; 7 : 2816 - 2820 .18 Berenguer M , Aguilera V , Prieto M , Ortiz C , Rodr\u00edguez M , Gentili F , et al .", "label": "", "metadata": {}, "score": "63.846138"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Hinrichsen , G. Leimenstoll , G. Stegen , H. Schrader , U. R. F\u00f6lsch , and W. E. Schmidt , \" Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients : a multicentre study in 2796 patients , \" Gut , vol .", "label": "", "metadata": {}, "score": "63.950176"}
{"text": "Epidemiology of Hepatitis C in Dialysis .There is a considerable variation in the incidence and prevalence of new cases of anti - HCV among dialysis centers [ 19 - 26 ] 44454650 risk factors for spread include a history of transfusions , number of blood products transfused , and number of years on hemodialysis .", "label": "", "metadata": {}, "score": "64.04801"}
{"text": "Most recent pretransplant therapy .The PI , NNRTI , PI and NNRTI , and nucleoside - only regimens included at least 2 nucleoside analogues ( except for 7 regimens that included a single nucleoside analogue ) .", "label": "", "metadata": {}, "score": "64.059814"}
{"text": "G - CSF was used in 21 patients ( 28 % ) and erythropoeitin in 1 patient , so there was not much trouble with anemia in this protocol .", "label": "", "metadata": {}, "score": "64.09471"}
{"text": "In summary , de novo and recurrent glomerulopathies are common in renal transplant patients with HCV infection and are associated with poorer allograft and patient survival .", "label": "", "metadata": {}, "score": "64.2894"}
{"text": "HCV and De Novo and Recurrent Glomerular Diseases .Chronic infection with HCV has been linked to the pathogenesis of glomerular diseases , both in native as well as transplanted kidneys .", "label": "", "metadata": {}, "score": "64.33037"}
{"text": "4 , pp .583 - 595 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Hepatitis C and Kidney Disease .", "label": "", "metadata": {}, "score": "64.43792"}
{"text": "Transjugular liver biopsy ( TJLB ) is an alternate means of obtaining liver tissue in patients with coagulopathy and suspected bleeding risk .The results of 46 hemodialysis patients with chronic liver disease undergoing TJLB were compared to 32 hemodialysis patients who had previously had a percutaneous liver biopsy at the same institution [ 25 ] .", "label": "", "metadata": {}, "score": "64.43857"}
{"text": "Early studies of ribavirin indicated that monotherapy with this oral nucleoside analogue was associated with improvements in ALT levels and liver histological characteristics in 30 % to 50 % of patients although ribavirin has little or no effect on HCV RNA levels [ 47 , 48 ] .", "label": "", "metadata": {}, "score": "64.441345"}
{"text": "J. Clin .Nutr .[ Google Scholar ] .Amin , A. ; Minaee , S. ; Chitsazan , M. ; Naderi , N. ; Taghavi , S. ; Ardeshiri , M. Can Vitamin D supplementation improve the severity of congestive heart failure ?", "label": "", "metadata": {}, "score": "64.44313"}
{"text": "Results of two phase II studies - PROVE 1 and PROVE 2-have shown safety and efficacy of the triple regimen of IFN \u03b1 -2a , ribavirin , and telaprevir in patients with untreated chronic HCV ( genotype 1 ) [ 54 , 55 ] .", "label": "", "metadata": {}, "score": "64.46369"}
{"text": "[ Google Scholar ] [ CrossRef ] .Forli , L. ; Bjortuft , O. ; Boe , J. Vitamin D status in relation to nutritional depletion and muscle function in patients with advanced pulmonary disease .", "label": "", "metadata": {}, "score": "64.51336"}
{"text": "Everson said treatment after transplant is unlikely to clear HCV - RNA .The number of transplants performed for recurrent , progressive , allograft Hepatitis C is increasing .", "label": "", "metadata": {}, "score": "64.54652"}
{"text": "2172 - 2178 , 2000 .View at Google Scholar \u00b7 View at Scopus .J. L. Calleja , A. Albillos , and A. Albillos , \" Sustained response to interferon- \u03b1 or to interferon- \u03b1 plus ribavirin in hepatitis C virus - associated symptomatic mixed cryoglobulinaemia , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "64.61558"}
{"text": "Gastroenterology 113:1668 , 1997 2 .Dodson SF , Issa S , Araya V , et al .Infectivity of hepatic allografts with antibodies to hepatitis B virus .", "label": "", "metadata": {}, "score": "64.69115"}
{"text": "Hence , it is routine to obtain genotype testing prior to initiation of treatment .Studies have shown that the prevalence of HCV genotypes in patients with ESRD is quite similar to that in the general population , with the majority of patients being infected with either genotype 1a or 1b [ 49 ] .", "label": "", "metadata": {}, "score": "64.69624"}
{"text": "Your feedback is important to us , so please let us know if you have comments or ideas for improvement .With dramatic improvements in the prognosis of individuals living with human immunodeficiency virus ( HIV ) on long - term antiretroviral therapy , end - stage liver disease has emerged as an important cause of morbidity and mortality . 1 , 2 Historically , HIV infection was viewed as a contraindication to liver transplantation ( LT ) because of concerns about immunosuppression - related opportunistic infections and reduced survival , but this is no longer the case .", "label": "", "metadata": {}, "score": "64.74049"}
{"text": "Kidney Int .[ Google Scholar ] [ CrossRef ] .Eur J. Clin .Pharmacol .[ Google Scholar ] .Trials 2009 , 10 , 36 .", "label": "", "metadata": {}, "score": "64.93947"}
{"text": "There was an equal distribution across all treatment arms .And they all resolved with dose reduction / discontinuation .Other adverse events occurring during the study : .", "label": "", "metadata": {}, "score": "64.95439"}
{"text": "Severe adverse events included pulmonary edema , cerebral hemorrhage , acute pancreatitis , cardiomyopathy , lymphoma , diplopia , and septic shock .Nevertheless , SVRs that have occurred in patients with advanced renal disease appear to be durable and clinically significant .", "label": "", "metadata": {}, "score": "64.95729"}
{"text": "In the most severe cases , plasmapheresis for 2 to 3 weeks can be helpful .Recent promising results suggest that monoclonal antibody to B cells ( anti - CD20 ; rituximab ) may be helpful in refractory cases [ 14 ] .", "label": "", "metadata": {}, "score": "65.019714"}
{"text": "Using a simple dilution algorithm , the quantitative Elecsys HBsAg II assay reliably determined serum HBsAg levels in a wide range of samples , and showed very high correlation with the Architect HBsAg assay .", "label": "", "metadata": {}, "score": "65.05357"}
{"text": "Int .[ Google Scholar ] .Dalle Carbonare , L. ; Zanatta , M. ; Braga , V. ; Sella , S. ; Vilei , M.T. ; Feltrin , G. ; Gambino , A. ; Pepe , I. ; Rossini , M. ; Adami , S. ; et al .", "label": "", "metadata": {}, "score": "65.073"}
{"text": "The CDC also recommends that dialysis units maintain surveillance records relevant to infection control .Patient records should include the location of the dialysis station , machine number , and names of attending staff members .", "label": "", "metadata": {}, "score": "65.257034"}
{"text": "Therefore , aggressive approaches designed to eradicate hepatitis C in patients with advanced liver disease awaiting transplant are needed .However , the most effective antiviral therapy , combination interferon plus ribivarin , is relatively contraindicated due to fear of precipitation of decompensation of liver disease or development of dangerous cytopenias .", "label": "", "metadata": {}, "score": "65.29149"}
{"text": "Kidney Int .[ Google Scholar ] .Stavroulopoulos , A. ; Porter , C.J. ; Roe , S.D. ; Hosking , D.J. ; Cassidy , M.J. Relationship between vitamin D status , parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4 .", "label": "", "metadata": {}, "score": "65.320694"}
{"text": "B ( 3 MU IFN 3x / wk ) : 2 patients in this arm achieved undetectable VL : 1 person with genotype 3a after 3 days on therapy and 1 person with genotype 2a / c after 2 weeks .", "label": "", "metadata": {}, "score": "65.36295"}
{"text": "Acquired hepatitis C de novo from an infected donor at transplantation , coinfection with both HBV and HCV , degree and form of immunosuppressive therapy have major effects on HCV titers after transplantation and consequently on disease outcome .", "label": "", "metadata": {}, "score": "65.41703"}
{"text": "J. Clin .Nutr .2008 , 88 , 558S-564S. [ Google Scholar ] .Van der Wielen , R.P. ; Lowik , M.R. ; van den Berg , H. ; de Groot , L.C. ; Haller , J. ; Moreiras , O. ; van Staveren , W.A. Serum vitamin D concentrations among elderly people in Europe .", "label": "", "metadata": {}, "score": "65.47037"}
{"text": "Endocrinol .Metab .[ Google Scholar ] .Pascussi , J.M. ; Robert , A. ; Nguyen , M. ; Walrant - Debray , O. ; Garabedian , M. ; Martin , P. ; Pineau , T. ; Saric , J. ; Navarro , F. ; Maurel , P. ; et al .", "label": "", "metadata": {}, "score": "65.479225"}
{"text": "With the shortage of donor organs , increasing number of hepatitis B core L patients who have been vaccinated against hepatitis B virus ( HBV ) and have developed hepatitis B surface antibodies ( HBsAb ) and in patients who are HBV carriers HBsAg ( ? )", "label": "", "metadata": {}, "score": "65.48633"}
{"text": "HBeAg positivity was associated with a higher biochemical disease activity and higher HBsAg levels in HDV co - infected patients .Sixty one per cent of the HBeAg - positive HDV - infected patients presented with HBV DNA levels below 2000 IU / ml , at least once during follow - up .", "label": "", "metadata": {}, "score": "65.52298"}
{"text": "The pathogenesis of these lesions is similar to what occurs in native kidneys - deposition of HCV - protein containing immune - complexes in the glomeruli , which occurs despite immunosuppressive therapy .", "label": "", "metadata": {}, "score": "65.64206"}
{"text": "Interestingly , a decrease in pro - brain natriuretic peptide and high - sensitivity C - reactive protein , as well as an improvement in six minute walk distance and New York Heart Association class was observed [ 20 ] .", "label": "", "metadata": {}, "score": "65.69507"}
{"text": "The higher rate of death in HCV - positive patients was due to cardiovascular disease ( hazard ratio ( HR ) 2.74 ) , malignancy ( HR 2.52 ) , and hepatic failure ( HR 22.1 ) .", "label": "", "metadata": {}, "score": "65.69685"}
{"text": "The 48-week boceprevir lead - in group achieved an SVR rate of 75 percent versus 38 percent for the standard of care group .", "label": "", "metadata": {}, "score": "65.742355"}
{"text": "V. Agnello , \" Mixed cryoglobulinemia and other extrahepatic manifestations of HCV infection , \" in Hepatitis C , T. J. Liang and J. H. Hoofnagle , Eds . , pp .", "label": "", "metadata": {}, "score": "65.896095"}
{"text": "Nutr .[ Google Scholar ] [ CrossRef ] .Bischoff - Ferrari , H.A. ; Dawson - Hughes , B. ; Stocklin , E. ; Sidelnikov , E. ; Willett , W.C. ; Edel , J.O. ; Stahelin , H.B. ; Wolfram , S. ; Jetter , A. ; Schwager , J. ; et al .", "label": "", "metadata": {}, "score": "65.91079"}
{"text": "Recently , a clinical practice guideline on the evaluation , treatment and prevention of vitamin D deficiency has been published by the Endocrine Society .According to this guideline , patients with hepatic failure are considered at high risk for vitamin D deficiency .", "label": "", "metadata": {}, "score": "65.951416"}
{"text": "Achievement of SVR may reduce the risks for both the hepatic and extrahepatic complications such as glomerulonephritis and NODAT associated with HCV .Patients who can not achieve SVR and have no live donor may be considered for HCV - positive kidneys .", "label": "", "metadata": {}, "score": "66.06445"}
{"text": "Bozorgzadeh A , Jain A , Ryan C , et al : Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living - donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus .", "label": "", "metadata": {}, "score": "66.135155"}
{"text": "Am .J. Nephrol .[ Google Scholar ] [ CrossRef ] .Stavroulopoulos , A. ; Cassidy , M.J. ; Porter , C.J. ; Hosking , D.J. ; Roe , S.D. Vitamin D status in renal transplant recipients .", "label": "", "metadata": {}, "score": "66.249115"}
{"text": "Antiviral therapy with interferon alfa has been found associated with improvements in cryoglobulins , rheumatoid factor , and creatinine levels and improving symptoms of immune complex disease .", "label": "", "metadata": {}, "score": "66.2787"}
{"text": "Patients with AIH , RA and HBV / HCV were tested for HEV RNA .HEV - specific proliferative T cell responses were investigated using CFSE staining and in vitro stimulation of PBMC with overlapping HEV peptides .", "label": "", "metadata": {}, "score": "66.285446"}
{"text": "Oral supplementation with ergocalciferol for six months , with 50,000 International Units per week for four weeks in the case of mild ( 5 to 15 ng / mL ) and 12 weeks in the case of severe ( below 5 ng / mL ) vitamin D deficiency is proposed .", "label": "", "metadata": {}, "score": "66.35812"}
{"text": "563 - 575 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. Finelli , J. T. Miller , J. I. Tokars , M. J. Alter , and M. J. Arduino , \" National surveillance of dialysis - associated diseases in the United States , 2002 , \" Seminars in Dialysis , vol .", "label": "", "metadata": {}, "score": "66.38952"}
{"text": "1179 - 1186 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. C. Gordon , J. D. Edgar , and R. G. Finch , \" Acute exacerbation of vasculitis during interferon - alpha therapy for hepatitis C - associated cryoglobulinemia , \" Journal of Infection , vol .", "label": "", "metadata": {}, "score": "66.40279"}
{"text": "Patients treated with tacrolimus showed a better correlation between both parameters than individuals receiving cyclosporine A. HCV RNA / HCVcoreAg ratios did not differ between transplanted and nontransplanted patients , and HCV RNA and HCVcoreAg kinetics were almost identical during the first days after liver transplantation .", "label": "", "metadata": {}, "score": "66.410355"}
{"text": "Hepatitis C ( HCV ) infection remains highly prevalent in patients with end - stage renal disease ( ESRD ) .The prevalence of HCV in dialysis patients varies among different parts of the world with up to 80 % in developing countries [ 1 ] and 1.8 % [ 2 ] and 40 % in developed countries [ 1 ] .", "label": "", "metadata": {}, "score": "66.428925"}
{"text": "High doses of recombinant erythropoietin are usually needed to alleviate the anemia [ 39 , 40 ] .This was accompanied , however , by a 41 % SVR rate , much greater than the 10 to 20 % SVR rates observed in previously published studies of nonhemodialysis patients treated with IFN monotherapy [ 42 , 43 ] .", "label": "", "metadata": {}, "score": "66.46321"}
{"text": "Now , he has carved out a remarkable life .After nearly two decades of chronic illness , Ashley and her family were ready for a liver transplant - and a fresh start .", "label": "", "metadata": {}, "score": "66.49794"}
{"text": "We will discuss in this paper chronic hepatitis C- related kidney disease and course and management of patients with chronic hepatitis C in special circumstances like hemodialysis and kidney transplantation .", "label": "", "metadata": {}, "score": "66.50659"}
{"text": "Distribution of Histologic Severity Among Rejection Episodes [ Time Frame : Immunosuppression to rejection ] [ Designated as safety issue : Yes ] .Incidence of Adverse Events [ Time Frame : throughout trial ] [ Designated as safety issue : Yes ] .", "label": "", "metadata": {}, "score": "66.53067"}
{"text": "[ Google Scholar ] [ CrossRef ] .\u00a9 2013 by the authors ; licensee MDPI , Basel , Switzerland .Liver Transplant .A liver transplant is surgery to remove a diseased or damaged liver and replace it with a healthy donor liver , either from a deceased donor or from a living donor .", "label": "", "metadata": {}, "score": "66.576324"}
{"text": "These immunomodulatory effects may be exploited in various diseases , including organ tolerance after transplantation .The increase in regulatory T - cells by nutritional vitamin D , as shown in a randomized controlled trial , could be of particular relevance in organ transplant recipients [ 63 ] .", "label": "", "metadata": {}, "score": "66.90245"}
{"text": "IFN DOSE REDUCTION .DRUGS DISCONTINUED .Less than half of the patients screened for this study met entry criteria , so they were a sick group in general .", "label": "", "metadata": {}, "score": "66.96996"}
{"text": "Newer therapies are under trial for the treatment of chronic hepatitis C ; these drugs are either modified derivatives of current treatments or newer drugs targeting HCV - encoded proteins or host - encoded proteins .", "label": "", "metadata": {}, "score": "67.03096"}
{"text": "Donor and nondonor parents will be asked to each provide one blood sample during the initial study visits for immunologic and genetic testing .Discontinuation of prescribed immunosuppressive therapy can result in serious health consequences and should only be performed in certain rare circumstances , upon the recommendation and with the guidance of your health care provider .", "label": "", "metadata": {}, "score": "67.10719"}
{"text": "HIV Disease After LT .HIV RNA was well controlled after LT .After transplantation , there were 3 cases of esophageal candidiasis , 1 case of candidiasis of bronchi , and 1 case of pneumocystosis .", "label": "", "metadata": {}, "score": "67.43388"}
{"text": "However , there was significant heterogeneity in SVR and drop - out rates among the studies .Prospective controlled trials are needed to assess the efficacy and tolerability of combined IFN or PEG - IFN with ribavirin compared to IFN or PEG - IFN monotherapy .", "label": "", "metadata": {}, "score": "67.44284"}
{"text": "Two PI - based regimens included raltegravir , and 1 PI - based regimen included enfuvirtide as well .Patient and Graft Survival .Patient / graft loss due to sepsis or multiorgan failure was more frequent for HCV / HIV - coinfected recipients versus HCV - infected recipients , and malignancy - related patient / graft loss was less frequent ( Table 2 ) .", "label": "", "metadata": {}, "score": "67.455894"}
{"text": "[ Google Scholar ] [ CrossRef ] .Courbebaisse , M. ; Thervet , E. ; Souberbielle , J.C. ; Zuber , J. ; Eladari , D. ; Martinez , F. ; Mamzer - Bruneel , M.F. ; Urena , P. ; Legendre , C. ; Friedlander , G. ; et al .", "label": "", "metadata": {}, "score": "67.489655"}
{"text": "[ Google Scholar ] [ CrossRef ] .Yilmaz , M.I. ; Sonmez , A. ; Saglam , M. ; Yaman , H. ; Kilic , S. ; Turker , T. ; Unal , H.U. ; Gok , M. ; Cetinkaya , H. ; Eyileten , T. ; et al .", "label": "", "metadata": {}, "score": "67.50571"}
{"text": "View at Google Scholar .O. H. Sameer , \" Hepatitis C in dialysis patients , \" Saudi Journal of Kidney Diseases and Transplantation , vol .", "label": "", "metadata": {}, "score": "67.5067"}
{"text": "The three telaprevir groups all received the same dose of telaprevir for 12 weeks along with either 12 , 24 , or 48 weeks of peginterferon plus ribavirin .", "label": "", "metadata": {}, "score": "67.52439"}
{"text": "6 , pp .1040 - 1048 , 1999 .View at Google Scholar \u00b7 View at Scopus .G. D'Amico and A. Fornasieri , \" Cryoglobulinemia , \" in Therapy in Nephrology and Hypertension , H. R. Brady and C. S. Wilcox , Eds . , pp .", "label": "", "metadata": {}, "score": "67.555145"}
{"text": "Nutr .[ Google Scholar ] [ CrossRef ] .Hossein - Nezhad , A. ; Spira , A. ; Holick , M.F. Influence of vitamin d status and vitamin d3 supplementation on genome wide expression of white blood cells : A randomized double - blind clinical trial .", "label": "", "metadata": {}, "score": "67.652756"}
{"text": "For the patients without the last 3 factors , the patient and graft survival rates were similar to those for US LT recipients .In conclusion , patient and graft survival rates are lower for HCV / HIV - coinfected LT patients versus HCV - monoinfected LT patients .", "label": "", "metadata": {}, "score": "67.65281"}
{"text": "5 , pp .1374 - 1380 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Baid - Agrawal , U. Frei , P. Reinke et al . , \" Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "67.87077"}
{"text": "Yet , there are no standardized regimens and long - term efficacy is not known .We report a case of a patient who underwent LT for alcoholic liver disease who received an allograft from a donor with Hepatitis B core antibody .", "label": "", "metadata": {}, "score": "67.96179"}
{"text": "In addition , a median alimentary intake of approximately 3.2 \u00b5g vitamin D per day was reported [ 49 ] .Moreover , clear seasonal variations in serum calcidiol levels were found in long - term kidney transplant recipients , with 3.5-times more patients reaching calcidiol above 30 ng / mL during summer months compared with winter months .", "label": "", "metadata": {}, "score": "68.02231"}
{"text": "In summary , studies in patients with organ failure consistently show that vitamin D insufficiency or deficiency is widespread among these patients , even in the healthier sub - population of patients awaiting transplantation .", "label": "", "metadata": {}, "score": "68.15404"}
{"text": "The aim of this study was to investigate the role of HBeAg in patients co - infected with the hepatitis D virus ( HDV ) .", "label": "", "metadata": {}, "score": "68.1645"}
{"text": "We conducted a prospective , multicenter US cohort study of HCV / HIV - coinfected LT recipients to define the natural history of the disease and predictors of graft survival and HCV disease recurrence .", "label": "", "metadata": {}, "score": "68.25131"}
{"text": "In particular , the active metabolite , 1,25-dihydroxyvitamin D , has immunomodulatory activity , which is supported by extensive experimental research ( reviewed in [ 61 , 62 ] ) .", "label": "", "metadata": {}, "score": "68.258484"}
{"text": "Everson speculates that clearance of HCV - RNA will : - Slow disease progression - Improve hepatic function - Reduce risk of post - transplant occurrence of Hepatitis C [ Show abstract ] [ Hide abstract ] ABSTRACT : Background Immigrant populations are believed to be more frequently infected with hepatitis viruses .", "label": "", "metadata": {}, "score": "68.309814"}
{"text": "[ Google Scholar ] .Sadlier , D.M. ; Magee , C.C. Prevalence of 25(OH ) vitamin D ( calcidiol ) deficiency at time of renal transplantation : A prospective study .", "label": "", "metadata": {}, "score": "68.319305"}
{"text": "Drug Targets 2011 , 12 , 29 - 41 .[ Google Scholar ] [ CrossRef ] .Pilz , S. ; Tomaschitz , A. ; Marz , W. ; Drechsler , C. ; Ritz , E. ; Zittermann , A. ; Cavalier , E. ; Pieber , T.R. ; Lappe , J.M. ; Grant , W.B. ; et al .", "label": "", "metadata": {}, "score": "68.37296"}
{"text": "Heart Fail .[ Google Scholar ] [ CrossRef ] .Costanzo , M.R. ; Dipchand , A. ; Starling , R. ; Anderson , A. ; Chan , M. ; Desai , S. ; Fedson , S. ; Fisher , P. ; Gonzales - Stawinski , G. ; Martinelli , L. ; et al .", "label": "", "metadata": {}, "score": "68.40315"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The use of extended criteria donors ( ECDs ) could minimize shortage of suitable donor livers for transplantation .", "label": "", "metadata": {}, "score": "68.41068"}
{"text": "These results suggest that patients with ESRD have a similar , if not better , likelihood of a sustained response to interferon alfa therapy for hepatitis C than patients without renal disease .", "label": "", "metadata": {}, "score": "68.54854"}
{"text": "Nephrologists ' Group for the Study of HCV infection , \" Journal of Viral Hepatitis , vol .4 , pp .113 - 119 , 1997 .", "label": "", "metadata": {}, "score": "68.58165"}
{"text": "Keywords : . vitamin D ; heart failure ; pulmonary disease ; liver failure ; chronic kidney disease ; transplantation ; calcidiol ; rejection ; supplementation ; guidelines .", "label": "", "metadata": {}, "score": "68.65909"}
{"text": "Liver Failure and Liver Transplantation .Vitamin D Status in Patients with End - Stage Liver Disease .The liver is the main site where hydroxylation of vitamin D at position C-25 takes place .", "label": "", "metadata": {}, "score": "68.8279"}
{"text": "The pooled SVR for IFN and PEG - IFN was 39.1 % ( 95 % CI , 32.1 to 46.1 ) and 39.3 % ( 95 % CI , 26.5 to 52.1 ) , respectively .", "label": "", "metadata": {}, "score": "68.8828"}
{"text": "Though most immunosuppressive agents increase viral replication , the implication is unclear .Selection of specific immunosuppressive regimens should be individualized and balanced between the potential effect on HCV - associated hepatic and extra - hepatic complications [ 19 ] .", "label": "", "metadata": {}, "score": "69.07731"}
{"text": "4 are in the last 3 months of treatment .DROPOUTS & COMPLICATIONS .There were 21 dropouts , 19 related to side effects and 2 due to non - compliance .", "label": "", "metadata": {}, "score": "69.15959"}
{"text": "The prevalence rates reported are 1%-29 % from Western Europe , 8%-36 % from North America , 5.9 % in Australia , and 44%-60 % in Far Eastern countries .", "label": "", "metadata": {}, "score": "69.18485"}
{"text": "Bland - Altman analysis showed only minor discordance between assays in different phases of chronic HBV - infection ( 3.8 - 5.1 % ) .This strong correlation was also present for sera with lower HBsAg concentrations .", "label": "", "metadata": {}, "score": "69.30896"}
{"text": "Am J Gastroenterol 1997 ; 92 : 1453 - 1457 .16 Frassetto LA , Browne M , Cheng A , Wolfe AR , Roland ME , Stock PG , et al .", "label": "", "metadata": {}, "score": "69.39398"}
{"text": "Characteristics of HCV / HIV - Coinfected Transplant Recipients and HCV - Monoinfected Transplant Recipients .P Value .The data are presented as medians and IQRs .", "label": "", "metadata": {}, "score": "69.407005"}
{"text": "Hence , whether PEG - IFN confers additional benefits in terms of SVR and adverse events is unclear .There are limited studies of the use of combined IFN or PEG - IFN with ribavirin in patients with advanced kidney disease .", "label": "", "metadata": {}, "score": "69.4362"}
{"text": "On electron microscopy , immune complexes are usually subendothelial and may have a finely fibrillar or tactoid pattern .Both subendothelial and mesangial immune complexes can be identified by electron microscopy , typically without distinctive substructure ( see Figure 2 ) .", "label": "", "metadata": {}, "score": "69.442085"}
{"text": "Most patients will have anti - HCV , as well as HCV RNA , in serum .Serum aminotransferase levels are elevated in 70 % of patients , and the majority have RF and low levels of complement .", "label": "", "metadata": {}, "score": "69.58404"}
{"text": "Patients with lower HCV RNA levels tend to have lower HCV RNA / HCVcoreAg ratios .HCVcoreAg represents a reliable marker of viral replication showing a good correlation with HCV RNA in various patient populations , with some limitations in HBV / HCV - coinfection .", "label": "", "metadata": {}, "score": "69.61905"}
{"text": "Cyclosporin A , inhibits HCV replication in cell culture replicon models [ 62 ] .A synthetic nonimmunosuppressive form of cyclosporin , Debio-025 , exhibits potent activity against both HCV and HIV in cell cultures [ 63 ] .", "label": "", "metadata": {}, "score": "69.80284"}
{"text": "PEG - IFN also has been studied in patients with ESRD .SVR rates between 45 % and 75 % have been observed with PEG - IFN monotherapy in hemodialysis patients [ 44 - 46 ] .", "label": "", "metadata": {}, "score": "69.83661"}
{"text": "Liver function tests correlate poorly with histological severity in HCV - positive patients receiving hemodialysis [ 20 , 21 ] .Furthermore , patients with ESRD have been found to have less histological activity on liver biopsy , characterized by less inflammation and less fibrosis compared with controls [ 21 , 22 ] .", "label": "", "metadata": {}, "score": "69.87575"}
{"text": "None of these , however , have been validated in the postkidney transplant population .Ultrasound elastography , known commercially as Fibroscan , has been evaluated as a noninvasive method to evaluate liver fibrosis in kidney transplant patients .", "label": "", "metadata": {}, "score": "69.92524"}
{"text": "HBV DNA , HCV RNA , HBsAg and HCV core antigen ( HCVcoreAg ) were quantified repeatedly in anti - HCV- and HBsAg - positive patients before and after haemodialysis .", "label": "", "metadata": {}, "score": "69.96715"}
{"text": "Nucleic acid test should be done in HCV - positive kidney donors if available .The effect of superinfection with a different HCV genotype when an HCV - positive kidney is transplanted into an HCV - positive recipient remains to be studied [ 18 ] .", "label": "", "metadata": {}, "score": "70.03674"}
{"text": "A champion for organ donation .Liver transplant physician Mohamed Hassan , MD , bridges the gap between organ donation and the East African community .", "label": "", "metadata": {}, "score": "70.06004"}
{"text": "Acknowledgments .Conflict of Interest .References .Stein , E.M. ; Shane , E. Vitamin D in organ transplantation .Osteoporos .Int .[ Google Scholar ] [ CrossRef ] .", "label": "", "metadata": {}, "score": "70.06581"}
{"text": "A careful evaluation to identify the cause of renal dysfunction should be undertaken in these patients .Use of interferon therapy should be avoided .All patients should receive antiproteinuric therapy as tolerated and antiviral treatment may be considered .", "label": "", "metadata": {}, "score": "70.12128"}
{"text": "Res .Rev. 2011 , 27 , 942 - 945 .[ Google Scholar ] [ CrossRef ] .Hopkins , M.H. ; Owen , J. ; Ahearn , T. ; Fedirko , V. ; Flanders , W.D. ; Jones , D.P. ; Bostick , R.M. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients : A randomized , controlled clinical trial .", "label": "", "metadata": {}, "score": "70.15762"}
{"text": "For these reasons , corticosteroids and cyclophosphamide continue to be used , when interferon therapy is ineffective [ 13 ] .Although these drugs may increase viral titers they have not been associated with worsening of the underlying hepatic disease .", "label": "", "metadata": {}, "score": "70.164185"}
{"text": "Interventional Studies and Guidelines .Despite the high prevalence of vitamin D insufficiency among patients with advanced heart failure and cardiac transplant recipients , interventional studies are sparse or lacking .", "label": "", "metadata": {}, "score": "70.23302"}
{"text": "HCV - RNA was quantified using a commercial bDNA signal amplification assay ( HCV Quantiplex 2.0 Chiron ) .Lower limit of sensitivity of the assay was 0.2 x 10 6 vEq / ml .", "label": "", "metadata": {}, "score": "70.25231"}
{"text": "Chronic Hepatitis C ( HCV ) infection is an important cause of morbidity and mortality in patients with end - stage renal disease .Renal transplantation confers a survival advantage in HCV - infected patients .", "label": "", "metadata": {}, "score": "70.60665"}
{"text": "CBC and Biochemistry done every 2 weeks and HCV PCR done every 3 months .The goal was to achieve standard full dose therapy of 3 MU 3x / week IFN plus 1000/1200 mg / day RBV .", "label": "", "metadata": {}, "score": "70.62932"}
{"text": "[ 59 ] .African Americans , patients older than 60 , diabetics and highly sensitized patients did not have significantly increased risk of death .", "label": "", "metadata": {}, "score": "70.76149"}
{"text": "Hepatology 2005 ; 41 : 779 - 789 .14 Marcos A , Eghtesad B , Fung JJ , Fontes P , Patel K , Devera M , et al .", "label": "", "metadata": {}, "score": "70.852394"}
{"text": "For bone health , adults are considered to require at least 600 to 800 International Units daily .For reaching calcidiol levels above 30 ng / mL , however , higher doses may be required ( 1500 to 2000 International Units ) .", "label": "", "metadata": {}, "score": "70.865715"}
{"text": "[ Google Scholar ] .Ishimura , E. ; Nishizawa , Y. ; Inaba , M. ; Matsumoto , N. ; Emoto , M. ; Kawagishi , T. ; Shoji , S. ; Okuno , S. ; Kim , M. ; Miki , T. ; et al .", "label": "", "metadata": {}, "score": "70.9465"}
{"text": "[ Google Scholar ] [ CrossRef ] .Ross , A.C. ; Manson , J.E. ; Abrams , S.A. ; Aloia , J.F. ; Brannon , P.M. ; Clinton , S.K. ; Durazo - Arvizu , R.A. ; Gallagher , J.C. ; Gallo , R.L. ; Jones , G. ; et al .", "label": "", "metadata": {}, "score": "71.29966"}
{"text": "AIDS 2008 ; 22 : 1979 - 1991 .11 Pineda JA , Romero - G\u00f3mez M , D\u00edaz - Garc\u00eda F , Gir\u00f3n - Gonz\u00e1lez JA , Montero JL , Torre - Cisneros J , et al . ; for Grupo Andaluz para el Estudio de las Enfermedades Infecciosas and Grupo Andaluz para el Estudio del H\u00edgado .", "label": "", "metadata": {}, "score": "71.34867"}
{"text": "In addition , there should be strict attention to cleaning and disinfecting items shared between patients and careful disposal of dialyzers and blood tubing after treatments .", "label": "", "metadata": {}, "score": "71.36232"}
{"text": "Figure 2 : Membranoproliferative Glomerulonephritis Type I on light ( a ) and Electron microscopy ( b ) .A light microscopy showing diffuse endothelial proliferation B arrow pointing at subendothelial deposits on EM .", "label": "", "metadata": {}, "score": "71.41257"}
{"text": "[ Google Scholar ] .Jacob , A.I. ; Sallman , A. ; Santiz , Z. ; Hollis , B.W. Defective photoproduction of cholecalciferol in normal and uremic humans .", "label": "", "metadata": {}, "score": "71.52754"}
{"text": "Clin .Endocrinol .( Oxf . )[ Google Scholar ] .Shroff , R. ; Wan , M. ; Rees , L. Can vitamin D slow down the progression of chronic kidney disease ?", "label": "", "metadata": {}, "score": "71.56413"}
{"text": "Thus , there are no clearly effective therapies for hepatitis C that can be used safely in renal transplant recipients .In view of this limitation , there has been an increased focus on the identification of and therapy for hepatitis C in patients with ESRD who are eligible for transplantation .", "label": "", "metadata": {}, "score": "71.65628"}
{"text": "With high dose , daily dose reduction by 25 % for 8 weeks .With low dose , daily dose reduction by 25 % for 4 weeks .", "label": "", "metadata": {}, "score": "71.67849"}
{"text": "After LT , patients with HCV monoinfection also experience an accelerated rate of disease progression , and recurrent HCV cirrhosis is the leading cause of graft loss among LT recipients .", "label": "", "metadata": {}, "score": "71.680115"}
{"text": "In addition , there is virtually no information on the use of peginterferon or interferon - ribavirin combination therapy .Ribavirin is cleared by the kidneys and causes dose - related hemolysis , which makes it contraindicated in patients with kidney disease .", "label": "", "metadata": {}, "score": "71.70869"}
{"text": "Vitamin D Status in Patients with End - Stage Heart Failure .Hypovitaminosis D is highly prevalent among patients with congestive heart failure , with 17 % to 57 % of the patients displaying severe vitamin D deficiency [ 13 , 14 ] .", "label": "", "metadata": {}, "score": "71.83699"}
{"text": "Treatment with vitamin D 3 prevented an increase in tumor necrosis factor alpha , as observed in placebo - treated patients , and increased interleukin 10 levels [ 19 ] .", "label": "", "metadata": {}, "score": "71.855545"}
{"text": "Conclusion .Chronic HCV infection is an important cause of morbidity and mortality in patients with ESRD .Kidney transplantation confers a survival advantage in HCV - infected patients .", "label": "", "metadata": {}, "score": "71.89191"}
{"text": "The next study discusses treatment in patients at an earlier stage and that may be a key .NE ; M Charlton , Mayo Clinic , Rochester , MN .", "label": "", "metadata": {}, "score": "72.08619"}
{"text": "Ascites ; 44 % .SBP : 7 % .Encepholopathy : 34 % .42 patients underwent endoscopy and 64 % of them had documented varisces .", "label": "", "metadata": {}, "score": "72.100525"}
{"text": "In mice with cryoglobulinemia and MPGN , use of imatinib led to the reduction in cryoglobulin production and the reversal of renal and systemic lesions [ 89 ] .", "label": "", "metadata": {}, "score": "72.30176"}
{"text": "These data provide the impetus to treat HCV - infected individuals while awaiting kidney transplantation .Interferon and Ribavirin .Combined PEG - IFN and ribavirin is considered the standard treatment for HCV infection in patients with normal renal function .", "label": "", "metadata": {}, "score": "72.311035"}
{"text": "J. Transplant .[ Google Scholar ] [ CrossRef ] .Am .J. Respir .Crit .Care Med .[ Google Scholar ] [ CrossRef ] .", "label": "", "metadata": {}, "score": "72.469055"}
{"text": "Models for the overall cohort were stratified by the case - matched group , and the predictor variable of interest was HIV / HCV coinfection .", "label": "", "metadata": {}, "score": "72.502266"}
{"text": "For example , lipoprotein metabolism is altered in uremic patients .The literature suggests that a component of uremic serum inhibits hepatic apolipoprotein A-1 synthesis [ 28 ] .", "label": "", "metadata": {}, "score": "72.53228"}
{"text": "Sirolimus was used at the discretion of the investigator and was typically part of a renal - sparing drug strategy .Target trough immunosuppressive levels were site - specified .", "label": "", "metadata": {}, "score": "72.56109"}
{"text": "In patients unable to tolerate or unresponsive to interferon therapy disease , amelioration can been achieved by using ribavirin alone [ 11 ] .Antiviral therapy can be successful in eradicating HCV in patients with cryoglobulinemia or glomerulonephritis , but sustained responses are uncommon [ 12 ] .", "label": "", "metadata": {}, "score": "72.581665"}
{"text": "In particular , based on expert consensus ( Level of Evidence C ) , the International Society of Heart and Lung Transplantation recommends a daily intake of 1000 to 1500 mg of calcium and 400 to 1000 International Units of vitamin D to all heart transplant candidates and recipients .", "label": "", "metadata": {}, "score": "72.60698"}
{"text": "27 However , any measurement bias related to the assessment of fibrosis severity would be nondifferential .In summary , this study highlights that patient and graft survival rates are lower for HCV - infected patients with HIV versus HCV - infected patients without HIV , but acceptable results are achievable in most coinfected patients .", "label": "", "metadata": {}, "score": "72.764496"}
{"text": "Int .[ Google Scholar ] [ CrossRef ] .Fisher , L. ; Fisher , A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease .", "label": "", "metadata": {}, "score": "72.76573"}
{"text": "From the current evidence , it is not clear whether vitamin D deficiency is one of the causative factors or a consequence in the development and progression of organ failure .", "label": "", "metadata": {}, "score": "72.79465"}
{"text": "Abstract . :Among patients with organ failure , vitamin D deficiency is extremely common and frequently does not resolve after transplantation .This review crystallizes and summarizes existing data on the status quo of vitamin D deficiency in patients with organ failure and in solid organ transplant recipients .", "label": "", "metadata": {}, "score": "72.9612"}
{"text": "Interferon should be avoided after kidney transplant except for treatment of life - threatening liver injury , such as fibrosing cholestatic hepatitis .Early detection , prevention , and treatment of complications due to chronic HCV infection may improve the outcomes of kidney transplant recipients with chronic HCV infection .", "label": "", "metadata": {}, "score": "72.97866"}
{"text": "Undetectable VLs are attainable .Adverse events are the rule and most patients do n't meet criteria ( to sick ) for treatment .Dose reduction / discontinuation is common as only 4 patients were able to complete 4 weeks therapy .", "label": "", "metadata": {}, "score": "73.05003"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : A quantitative HCV core antigen ( HCVcoreAg ) immunoassay has been developed for the confirmation of viremia in patients with hepatitis C. We evaluated the correlation of HCV RNA and HCVcoreAg in different patient populations without HCV - specific treatment : HIV / HCV - coinfection , HBV / HCV - coinfection , and patients with end - stage renal disease .", "label": "", "metadata": {}, "score": "73.07738"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. K. Gupta , S. L. Rosenkranz , Y. S. Cramer et al . , \" The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir / ritonavir in HIV - infected persons requiring hemodialysis , \" AIDS , vol .", "label": "", "metadata": {}, "score": "73.16095"}
{"text": "The treatment of acute rejection in HCV - infected LT recipients is a well - recognized risk factor for recurrent cirrhosis and graft loss .12 , 22 The finding of a significantly higher rate of acute rejection for HCV / HIV - coinfected recipients versus HCV - monoinfected recipients is a critically important finding of our study because the prevention of acute rejection may offer a means of optimizing outcomes for HIV / HCV - coinfected recipients .", "label": "", "metadata": {}, "score": "73.17929"}
{"text": "Table 3 summarizes the prevalence of vitamin D insufficiency , deficiency and severe deficiency in patients with end - stage liver disease and liver transplant recipients .", "label": "", "metadata": {}, "score": "73.43644"}
{"text": "The Committee on Human Research at the University of California San Francisco approved the study protocol , as did the institutional review board of each participating center .", "label": "", "metadata": {}, "score": "73.46053"}
{"text": "In addition , hepatitis E virus ( HEV ) reactivation was reported after hematopoietic stem cell transplantation ( HSCT ) .Of note , none of the subjects tested positive for HEV RNA , including 2 HSCT patients who had been infected with HEV already before transplantation .", "label": "", "metadata": {}, "score": "73.490845"}
{"text": "In this review , we consider 25-hydroxyvitamin D ( calcidiol ) levels below 30 ng / mL as insufficiency or hypovitaminosis , below 20 ng / mL as deficiency and below 10 ng / mL as severe deficiency ( \u00d72.5 for conversion to nmol / L ) .", "label": "", "metadata": {}, "score": "73.753265"}
{"text": "The authors thank Rodney Rogers for his expert coordination of the study consortium .They also thank all the Solid Organ Transplantation in HIV : Multi - Site Study investigators and coordinators for their hard work and dedication to the study and subjects .", "label": "", "metadata": {}, "score": "73.78282"}
{"text": "Chronic hepatitis E may explain elevated liver enzymes in heart transplant recipients .Treatment of HEV infection with ribavirin is effective but the optimal dose and duration of ribavirin therapy remains to be determined .", "label": "", "metadata": {}, "score": "73.96065"}
{"text": "End - Stage Pulmonary Disease and Lung Transplantation .Vitamin D Status in Patients with End - Stage Pulmonary Disease .In end - stage pulmonary disease patients , varying prevalence of vitamin D deficiency was reported depending on the underlying disease .", "label": "", "metadata": {}, "score": "74.038734"}
{"text": "Antiretroviral therapy was determined by the HIV provider in consultation with transplant team physicians who had expertise in HIV management .Most patients continued their pretransplant regimen in the posttransplant period .", "label": "", "metadata": {}, "score": "74.063446"}
{"text": "Achievement of sustained virological response ( SVR ) may reduce the risks for both posttransplantation hepatic and extrahepatic complications such as de novo or recurrent glomerulonephritis associated with HCV .", "label": "", "metadata": {}, "score": "74.24624"}
{"text": "In 50 ESRD patients , it was found to have a positive predictive value ( PPV ) of 75 % to detect Metavir F2-F4 for scores greater than 0.60 , with a negative predictive value ( NPV ) of 71 % for scores lower than 0.20 [ 26 ] .", "label": "", "metadata": {}, "score": "74.53802"}
{"text": "However , its effect on HCV clinically is unclear .Whether mycophenolate is detrimental in terms of graft and patient survival in kidney transplant patients with chronic HCV infection is unclear [ 19 ] .", "label": "", "metadata": {}, "score": "74.68704"}
{"text": "Sustained viral remission is rare ( 12 % ) .Once you stop treatment the relapse rate is high .But if patients are able to achieve SVR , they do not appear to relapse post - transplant .", "label": "", "metadata": {}, "score": "74.73819"}
{"text": "Norah A. Terrault , Michelle E. Roland , Burc Barin , Donald M. Stablein , and Peter G. Stock contributed to the drafting of the manuscript .", "label": "", "metadata": {}, "score": "74.7414"}
{"text": "For vitamin D insufficiency , ergocalciferol at a monthly dose of 50,000 International Units orally for six months is suggested .All of these recommendations are opinion - based [ 52 ] .", "label": "", "metadata": {}, "score": "74.75261"}
{"text": "The pathogenesis of the glomerular injury in HCV infection is believed to result from deposition of circulating immune complexes of HCV , anti - HCV , and RF at the site of injury .", "label": "", "metadata": {}, "score": "74.80321"}
{"text": "Our results indicate that HCV per se is not a contraindication to LT in HIV patients , but recipient and donor selection and the management of acute rejection strongly influence outcomes .", "label": "", "metadata": {}, "score": "74.95299"}
{"text": "In addition to standard universal precautions , additional practices are recommended because exposure to blood is routinely anticipated [ 27 , 28 ] .These recommendations include special dialysis unit precautions , regular serological testing , active surveillance , and training and education .", "label": "", "metadata": {}, "score": "75.10382"}
{"text": "Other forms of glomerular injury reported in patients with HCV infection include membranous glomerulonephritis , IgA nephropathy , postinfectious glomerulonephritis , focal and segmental glomerulosclerosis , fibrillary glomerulonephritis , and immunotactoid glomerulopathy [ 6 , 7 ] .", "label": "", "metadata": {}, "score": "75.216576"}
{"text": "The rate of false negative results is quite low with a third generation immunoassay in patients on hemodialysis [ 15 ] .The risk of reactivation in patients who are HCV antibody positive but HCV RNA negative is extremely rare , even in situations of considerable immunosuppression .", "label": "", "metadata": {}, "score": "75.240486"}
{"text": "HCV core antigen ( HCVcoreAg ) testing could be an alternative to NAT with some potential advantages including very low intra- and interassay variabilities and lower costs .", "label": "", "metadata": {}, "score": "75.2507"}
{"text": "For a minimum of 3 and up to a maximum of 7 years , monthly telephone consultations and quarterly study visits will occur .Visits will include physical exams and blood collection to monitor the children 's health during the withdrawal phase .", "label": "", "metadata": {}, "score": "75.35439"}
{"text": "Studies have shown that serum HBsAg quantification during , and at end of , treatment may predict long - term HBsAg loss .Performance comparison of the qualitative Elecsys HBsAg II assay using a quantitative research protocol and an established quantitative HBsAg assay .", "label": "", "metadata": {}, "score": "75.59739"}
{"text": "Polymerase Inhibitors .Development of a number of promising HCV polymerase inhibitors has been halted due to their toxicity .A phase I trial of R7128 combined with peginterferon and ribavirin in 50 genotype 1 treatment - na\u00efve patients yielded an impressive 85 percent rate of undetectable HCV RNA following four weeks of treatment compared to a 10-percent rate in patients receiving peginterferon and ribavirin alone [ 61 ] .", "label": "", "metadata": {}, "score": "75.637665"}
{"text": "In contrast , a high level of concordance was found between the Enzygnost and Ortho assays ( 80 % ) .The Monolisa was best to identify negative samples ( 100 % ) , while the Enzygnost correctly classified most of the positive samples ( 96 % ) .", "label": "", "metadata": {}, "score": "75.657234"}
{"text": "Long - term remission in cryoglobulinemia can occur with interferon therapy and response rates are similar in patients with hepatitis C without cryoglobulinemia .Higher doses of interferon and combination therapy with ribavirin yield greater response rates , but relapses and nonresponses still occur [ 8 , 9 ] .", "label": "", "metadata": {}, "score": "75.67299"}
{"text": "used rituximab in 7 renal transplant patients ( 5 of who were HCV positive ) with MPGN associated with mixed cryoglobulinemia [ 88 ] .Use of 2 - 4 doses of rituximab was associated with a sustained clearance of cryoglobulins and a significant reduction in proteinuria .", "label": "", "metadata": {}, "score": "75.92566"}
{"text": "Hepatology 1999 ; 29 : 250 - 256 .23 Jain AK , Venkataramanan R , Shapiro R , Scantlebury VP , Potdar S , Bonham CA , et al .", "label": "", "metadata": {}, "score": "75.93213"}
{"text": "Other nonspecific antiproteinuric therapies such as blockade of the renin - angiotensin - aldosterone system with angiotensin - converting enzyme inhibitors and angiotensin - receptor blockers may also be used as tolerated .", "label": "", "metadata": {}, "score": "76.10445"}
{"text": "Michelle E. Roland and Peter G. Stock obtained funding .Norah A. Terrault , Michelle E. Roland , Laurie Carlson , Jonah Odim , Lawrence Fox , and Peter G. Stock contributed to the supervision of the study .", "label": "", "metadata": {}, "score": "76.36066"}
{"text": "Conclusion Hepatitis virus infections are indeed significantly more prevalent in immigrant populations as compared with the general German population .These data underline the importance of introducing screening programs in this particular risk group .", "label": "", "metadata": {}, "score": "76.440414"}
{"text": "Patients who received telaprevir and PEG - IFN without ribavirin were less likely to achieve HCV RNA suppression and more likely to relapse than were those who received the triple combination .", "label": "", "metadata": {}, "score": "76.46778"}
{"text": "26 Other studies have shown that the homeostatic expansion of T cells in HIV - infected patients is often coupled with the acquisition of a memory phenotype , which in turn is associated with an increased responsiveness of T cells and a nonspecific enhancement of alloimmunity .", "label": "", "metadata": {}, "score": "76.50149"}
{"text": "Potential Conflicts of Interest : Dr. Schiano consults for Vertex , Merck , Salix , and Gilead .Dr. Poordad advises and received grants from Abbott , Anadys , Achillion , and Tibotec .", "label": "", "metadata": {}, "score": "76.51753"}
{"text": "Moreover , serum vitamin D binding protein and albumin substantially increased , which according to the authors , might have contributed to the marked improvement in vitamin D status by facilitating a shift of calcidiol from the adipose tissue to the circulation .", "label": "", "metadata": {}, "score": "76.558395"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : HCV RNA levels correlate with the long - term outcome of hepatitis C in liver transplant recipients .", "label": "", "metadata": {}, "score": "76.56441"}
{"text": "[ Google Scholar ] [ CrossRef ] .Thiem , U. ; Borchhardt , K. Vitamin D in solid organ transplantation with special emphasis on kidney transplantation .", "label": "", "metadata": {}, "score": "76.734375"}
{"text": "Vitamin D deficiency is also commonly observed in the general population [ 9 ] .In non - institutionalized elderly people across 11 European countries , 36 % of men and 47 % of women showed calcidiol levels below 12 ng / mL during winter [ 11 ] .", "label": "", "metadata": {}, "score": "76.841995"}
{"text": "After transplantation , the avoidance of sunlight , due to the increased risk of skin cancer in immunosuppressed patients [ 6 ] , may be the main factor causing vitamin D deficiency [ 7 ] .", "label": "", "metadata": {}, "score": "76.89664"}
{"text": "The overall SVR rates for the four arms were 51 , 52 , 23 , and 14 percent , respectively .Boceprevir .It is another protease inhibitor currently in phase III trials .", "label": "", "metadata": {}, "score": "77.350266"}
{"text": "Development of levovirin has been terminated since it was found to be inferior to ribavirin in combination with peginterferon [ 54 ] .Similarly , taribavirin , a prodrug of ribavirin has failed to show non - inferiority to ribavirin in two phase III trials .", "label": "", "metadata": {}, "score": "77.36669"}
{"text": "Hepatitis A virus ( HAV ) infection is common in industrialized and developing countries .While HAV infection is associated with a low mortality rate , the virus can produce significant morbidity among infected persons .", "label": "", "metadata": {}, "score": "77.493835"}
{"text": "A short course of HBIg - lamivudine combination therapy provides effective prophylaxis against HBV infection in 89 % of recipients of HBcAb(+ ) grafts .Full - text . antibody ( HBcAb)-positive [ HBcAb ( ? ) ] liver allografts are being used for liver trans- plantation ( LTx ) in patients who are HBcab - negative [ HBsAb ( ? ) ] This study was aimed at assessing outcomes for hepatitis C virus ( HCV)-positive [ HCV ( ? ) ] and HCV - negative [ HCV ( ? ) ] patients who received HBcAb ( ? ) liver grafts from deceased donors and also received a short course of hepatitis B immunoglobulin ( HBIg ) with long - term lamivudine therapy after LTx .", "label": "", "metadata": {}, "score": "77.61571"}
{"text": "J. Clin .Investig .[ Google Scholar ] .Int .[ Google Scholar ] [ CrossRef ] .Yetley , E.A. Assessing the vitamin D status of the US population .", "label": "", "metadata": {}, "score": "77.950966"}
{"text": "Transpl Int 2010 ; 23 : 1038 - 1044 .22 Prieto M , Berenguer M , Ray\u00f3n JM , C\u00f3rdoba J , Arg\u00fcello L , Carrasco D , et al .", "label": "", "metadata": {}, "score": "78.01174"}
{"text": "5 , pp .839 - 844 , 1985 .View at Google Scholar \u00b7 View at Scopus .43 , no . 1 , pp .", "label": "", "metadata": {}, "score": "78.15368"}
{"text": "Percutaneous live biopsy is a safe procedure when performed by experienced operators ; however , patients with cirrhosis and other bleeding diatheses can often have an increased risk of hemorrhage requiring hospitalization .", "label": "", "metadata": {}, "score": "78.18796"}
{"text": "In this study , HCV - infected LT recipients with HIV were found to have significantly lower graft and patient survival than HCV - infected recipients without HIV .", "label": "", "metadata": {}, "score": "78.200645"}
{"text": "LADR is warranted in decompensated cirrhotics .Genotype 1 patients who become RNA negative on treatment should be maintained on IFN+RBV until time of transplant .", "label": "", "metadata": {}, "score": "78.298386"}
{"text": "It is difficult to draw conclusions on recommendations as the results are quite varied .Treatment efficacy and tolerability of PEG - IFN in patients with ESRD need to be confirmed in a larger prospective clinical trial .", "label": "", "metadata": {}, "score": "78.662964"}
{"text": "Patients with autoimmune hepatitis but not RA or HBV / HCV patients are more likely to test anti - HEV positive .HEV infection should been ruled out before the diagnosis of AIH is made .", "label": "", "metadata": {}, "score": "78.8342"}
{"text": "HCV - Associated Glomerular Lesions after Transplantation .Membranoproliferative glomerulonephritis ( MPGN ) , with or without cryoglobulinemia is the most common renal lesion associated with chronic HCV infection in the renal transplant recipients [ 74 , 75 ] .", "label": "", "metadata": {}, "score": "78.89782"}
{"text": "Clinically , patients may have symptoms of cryoglobulinemia , including palpable purpura , arthralgias , neuropathy , and weakness .Renal manifestations include nephrotic or nonnephrotic proteinuria and microscopic hematuria [ 5 - 7 ] .", "label": "", "metadata": {}, "score": "78.98781"}
{"text": "3 However , the results for HIV - infected LT recipients with hepatitis C virus ( HCV ) are generally worse than those for recipients without HCV , 4 - 7 and this makes HCV a controversial indication for LT in HIV - infected patients .", "label": "", "metadata": {}, "score": "79.043594"}
{"text": "Chronic hepatitis E has been reported in some cohorts of immunocompromised individuals .The role of HEV infections in patients with autoimmune hepatitis ( AIH ) is unknown .", "label": "", "metadata": {}, "score": "79.04613"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Hepatitis C virus ( HCV ) and hepatitis B virus ( HBV ) infections are common in haemodialysis units .", "label": "", "metadata": {}, "score": "79.30934"}
{"text": "Discover Our Difference .University of Minnesota Health surgeons have performed more than 1,400 liver transplants since the program began in 1969 .The University of Minnesota Solid Organ Transplant Program has a long legacy of excellence in training doctors around the world in transplantation and in providing expert care to liver transplant patients .", "label": "", "metadata": {}, "score": "79.37625"}
{"text": "Rituximab may be tried in refractory cases .HCV and New Onset Diabetes after Transplantation .HCV has been associated with diabetes mellitus in both pre- and posttransplant patients .", "label": "", "metadata": {}, "score": "79.425"}
{"text": "Division of Nephrology and Dialysis , Department of Internal Medicine III , Medical University of Vienna , Spitalgasse 23 , Vienna 1090 , Austria .Author to whom correspondence should be addressed ; Tel . : +43 - 1 - 40400 - 4390 ; Fax : +43 - 1 - 40400 - 4392 .", "label": "", "metadata": {}, "score": "79.46982"}
{"text": "Protease Inhibitors .The incomplete effectiveness of treatment with PEG - IFN and ribavirin has prompted the development of selective inhibitors of HCV .The NS3/4A protease inhibitors , which specifically target viral replication , have been shown to have potent antiviral activity in HCV replicon assays .", "label": "", "metadata": {}, "score": "79.48886"}
{"text": "Patients diagnosed with diabetes mellitus as defined by the American Diabetic Association criteria should be referred to the diabetologist for further evaluation and management [ 19 ] .", "label": "", "metadata": {}, "score": "79.575294"}
{"text": "Figure 1 : ( a ) Classical Cryoglobulinemia - related small vessel vasculitis of lower extremities characterized by erythematosus palpable maculopapular rash in a HCV positive patient ( b ) Cryoglobulin precipitates in serum .", "label": "", "metadata": {}, "score": "79.8576"}
{"text": "HCV and Immunosuppression .The impact of chronic immunosuppression on the course of HCV infection in renal transplant recipients is not well defined .Corticosteroids at high doses have been shown to increase HCV viremia , probably by upregulation of cell entry factors such as occludin and scavenger receptor class B type 1 , and result in HCV dissemination [ 62 ] .", "label": "", "metadata": {}, "score": "79.87066"}
{"text": "Cyclophosphamide improves renal disease by suppressing B - lymphocyte stimulation and cryoglobulin production .However , such therapies are associated with a high rate of morbidity and mortality even in immunocompetent patients [ 84 ] .", "label": "", "metadata": {}, "score": "80.23869"}
{"text": "The mechanisms for HCV - associated diabetes mellitus are multiple and include increased insulin resistance , impaired insulin sensitivity [ 93 ] , reduced hepatic glucose uptake and glycogenesis , and direct viral cytopathic effect on pancreatic \u03b2 cells [ 90 ] .", "label": "", "metadata": {}, "score": "80.307785"}
{"text": "Seronegative viral hepatitis is rare in German maintenance haemodialysis patients .HCV RNA and HCVcoreAg decline during haemodialysis indicating a potential beneficial effect of haemodialysis during antiviral therapy of hepatitis C , which does not apply to HBV infection .", "label": "", "metadata": {}, "score": "80.37143"}
{"text": "The diagnosis of HEV infection should be based on HEV RNA determination in immunosuppressed patients .We suggest that immunocompromised individuals should avoid eating uncooked meat and contact with possibly HEV - infected animals .", "label": "", "metadata": {}, "score": "80.48864"}
{"text": "Increased physical activity , weight loss , and treatment of the various components of the metabolic syndrome are important aspects in the management of NODAT .", "label": "", "metadata": {}, "score": "80.63057"}
{"text": "Prospective trials to fully investigate the role of rituximab in this population are warranted .Novel therapies like imatinib are being studied in animal models for the treatment of cryoglobulinemia and MPGN .", "label": "", "metadata": {}, "score": "80.70975"}
{"text": "HBV DNA levels are low in both HBeAg - negative and HBeAg - positive patients suggesting suppressive effects of HDV on HBV irrespective of the phase of HBV infection .", "label": "", "metadata": {}, "score": "80.91234"}
{"text": "Publisher conditions are provided by RoMEO .Differing provisions from the publisher 's actual policy or licence agreement may be applicable .[ Show abstract ] [ Hide abstract ] ABSTRACT : The use of allografts from donors with hepatitis B core antibody in liver transplantation ( LT ) is associated with the risk of de novo hepatitis B virus ( HBV ) infection .", "label": "", "metadata": {}, "score": "80.97464"}
{"text": "Prophylaxis with short - term HBIg ( 1 week ) and indefinite lamivudine was given .De novo HBV infection developed more than 3 years after LT with a lamivudine - resistant polymerase mutant containing the rtM204I and rtl180L / M mutations .", "label": "", "metadata": {}, "score": "81.118546"}
{"text": "In cryoglobulinemic glomerulonephritis , high - dose intravenous pulse steroids followed by steroid taper can be used for the treatment of severe nephritic or nephrotic proteinuria associated with renal dysfunction .", "label": "", "metadata": {}, "score": "81.2508"}
{"text": "The summary estimates for SVR and drop - out rate were 56 % ( 95 % CI , 28 to 84 ) and 25 % ( 95 % CI , 10 to 40 ) , respectively .", "label": "", "metadata": {}, "score": "81.26964"}
{"text": "Thus , chronic HEV infections seem to be rare events in CVID patients in Germany .Commercially available immunoglobulin infusions contain anti HEV antibodies and may contribute to protection from HEV infection .", "label": "", "metadata": {}, "score": "81.37422"}
{"text": "Different performances may have cost and management implications , as false - positive results are not infrequent .However , sensitivities were good for all assays if indeterminate results are not considered as negative .", "label": "", "metadata": {}, "score": "81.56015"}
{"text": "He consults , advises , is on the speakers ' bureau for , and received grants from Bristol Meyers Squibb and Tibotec .He also received grants from Vertex .", "label": "", "metadata": {}, "score": "82.1983"}
{"text": "HCV Treatment in Renal Transplant Candidates .Chronic HCV infection leads to significant long - term morbidity and mortality in kidney transplant recipients .The treatment of HCV with interferon ( IFN ) after transplantation should be avoided because of an increased risk of rejection [ 1 , 3 , 18 ] .", "label": "", "metadata": {}, "score": "82.40545"}
{"text": "Correlation of HBsAg and HBV - DNA was weak or missing when analyzing different phases of persistent HBV - infection separately . HBsAg levels show significant differences during the natural course of HBV - infection and between HBV - genotypes .", "label": "", "metadata": {}, "score": "82.550964"}
{"text": "Nephrol .[ Google Scholar ] .Di Rosa , M. ; Malaguarnera , M. ; Nicoletti , F. ; Malaguarnera , L. Vitamin D3 : A helpful immuno - modulator .", "label": "", "metadata": {}, "score": "82.76631"}
{"text": "However , the assay is not recommended to monitor antiviral therapies .[ Show abstract ] [ Hide abstract ] ABSTRACT : Chronic courses of hepatitis E virus ( HEV ) infections have been described in immunosuppressed patients .", "label": "", "metadata": {}, "score": "82.920456"}
{"text": "Thus , it interferes with monoclonal IgM production , cryoglobulin synthesis and renal deposition of immune complexes .Rituximab has been used successfully for the treatment of cryoglobulinemia in non - immunocompromised patients [ 86 , 87 ] .", "label": "", "metadata": {}, "score": "83.33969"}
{"text": "Vitamin D deficiency is very common in patients with chronic kidney disease ( CKD ) across all stages .In North America , a prevalence of vitamin D insufficiency of approximately 85 % was reported among patients with advanced kidney disease [ 41 , 42 ] .", "label": "", "metadata": {}, "score": "83.412605"}
{"text": "In Table 4 , details on the vitamin D status in CKD patients and renal transplant patients are presented .Interventional Studies and Guidelines .Even though vitamin D deficiency is extremely common among patients with chronic kidney disease , including renal transplant recipients , there is no consensus on how to treat vitamin D deficiency in these patients .", "label": "", "metadata": {}, "score": "83.699005"}
{"text": "If ALT levels are persistently abnormal despite the absence of anti - HCV , testing for HCV RNA by qualitative assay ( such as polymerase chain reaction ) should be considered .", "label": "", "metadata": {}, "score": "83.85812"}
{"text": "Burc Barin and Donald M. Stablein have full access to all data in this study and take responsibility for the integrity of the data and the accuracy of the data analysis .", "label": "", "metadata": {}, "score": "84.407745"}
{"text": "5 , 6 Importantly , however , our study has uniquely evaluated predictors of poor outcomes and provides for the first time insights into critical patient selection and management strategies for maximizing good outcomes .", "label": "", "metadata": {}, "score": "86.12558"}
{"text": "4 , pp .997 - 1002 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .15 , no . 7 , pp .", "label": "", "metadata": {}, "score": "86.187256"}
{"text": "The author said the scary part of the study was the infectious complications occurring .He said most of these patients run into problems with infections .", "label": "", "metadata": {}, "score": "86.53046"}
{"text": "This beneficial effect was not demonstrated with cyclosporine , tacrolimus , sirolimus , azathioprine and steroids .Interestingly , in the same study , the use of antilymphocyte antibody induction was not associated with lower patient survival [ 66 ] .", "label": "", "metadata": {}, "score": "86.73903"}
{"text": "He is also on the speakers ' bureau for Salix and Onyx and received grants from Bristol Meyers Squibb , Pharmasset , and Boehringer Ingleheim .", "label": "", "metadata": {}, "score": "86.87394"}
{"text": "Recommendations and Reports , vol .47 , no .19 , pp . 1 - 39 , 1998 .View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "86.96858"}
{"text": "Baseline testing should include serum ALT levels and assays for both HBV and HCV infection .For anti - HCV - negative patients , recommended monitoring includes testing ALT levels monthly and anti - HCV every 6 months .", "label": "", "metadata": {}, "score": "87.148094"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Increased frequencies of HEV infections have been reported in several industrialized countries .We suggest that this finding might be explained by a better awareness of the disease and not by an increased incidence .", "label": "", "metadata": {}, "score": "87.43852"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Hepatitis E virus ( HEV ) infection induces self - limiting liver disease in immunocompetent individuals .", "label": "", "metadata": {}, "score": "87.51735"}
{"text": "In these patients , typical symptoms are fatigue and palpable purpura , which histologically consists of a leukocytoclastic vasculitis ( with complexes of anti - HCV and HCV in injured tissue ) ; see Figure 1 .", "label": "", "metadata": {}, "score": "87.63841"}
{"text": "Immunological and serologic studies , especially cryoglobulin and complement levels , may be useful in the diagnosis of cryoglobulinemic MPGN .Electron microscopy can help to distinguish these entities , especially in patients with noncryoglobulinemic MPGN .", "label": "", "metadata": {}, "score": "87.808075"}
{"text": "Recommendations and Reports , vol .50 , no .5 , pp . 1 - 43 , 2001 .View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "87.91148"}
{"text": "Albinterferon .It is a form of interferon alfa which is genetically fused to albumin .Its advantages are its long half - life and improved side effect profile [ 50 ] .", "label": "", "metadata": {}, "score": "88.33356"}
{"text": "CONCLUSIONS : .In this group of patients who are already at high risk , fatal complications can occur .Undetectable VLs can occur and tolerability is low .", "label": "", "metadata": {}, "score": "88.73157"}
{"text": "3 Immunosuppression was not standardized , but the study protocol strongly recommended specific immunosuppressive drugs , and adherence to those recommendations was high .Maintenance immunosuppression included a calcineurin inhibitor [ cyclosporine A ( CSA ) or tacrolimus ( TAC ) ] , mycophenolate mofetil ( MMF ) , and prednisone .", "label": "", "metadata": {}, "score": "88.773026"}
{"text": "3a- 1 .untypeable- 2 .BASELINE VIRAL LOAD .Undetectable- 3 patients .5.0 - 10 vEq / ml- 1 .VIRAL RESPONSE .4/12 patients ( 33 % ) with detectable viral load at baseline achieved undetectable VL on treatment .", "label": "", "metadata": {}, "score": "88.79833"}
{"text": "6 , pp .2082 - 2084 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .28 , no . 1 , pp .", "label": "", "metadata": {}, "score": "88.99001"}
{"text": "On the other hand , low calcidiol levels might simply reflect poorer health status in patients with advanced stages of organ failure .At present , there are only a few recommendations on how to manage vitamin D deficiency in these patients ; most of them are based on expert consensus and derived from the beneficial effects of vitamin D on the skeleton .", "label": "", "metadata": {}, "score": "89.38754"}
{"text": "This content is owned by the AAFP .A person viewing it online may make one printout of the material and may use that printout only for his or her personal , non - commercial reference .", "label": "", "metadata": {}, "score": "89.92196"}
{"text": "94 , no .12 , pp .3576 - 3582 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "90.11366"}
{"text": "Contact afpserv@aafp.org for copyright questions and/or permission requests .Antirejection medicines , also known as immunosuppressive drugs , are prescribed to organ transplant recipients to prevent their bodies from rejecting the new organ .", "label": "", "metadata": {}, "score": "90.42442"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Abstract Anti - HCV testing is the first step to diagnose hepatitis C. Although anti - HCV assay performance improved during the last 2 decades , very high sensitivity required for screening may lead to limitations in specificity .", "label": "", "metadata": {}, "score": "90.492065"}
{"text": "12 , no . 7 , pp .1414 - 1419 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "90.77301"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The quantifiable level of HBsAg has been suggested as a predictor of treatment response in chronic hepatitis B. However , there is limited information on HBsAg levels considering the dynamic natural course of HBV - infection .", "label": "", "metadata": {}, "score": "91.395485"}
{"text": "Talk with your doctor and family members or friends about deciding to join a study .To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .", "label": "", "metadata": {}, "score": "91.798035"}
{"text": "Vitamin D deficiency is a commonly observed phenomenon in patients with organ failure and solid organ transplant recipients .It occurs in patients with different types of solid organ transplant and frequently persists even in the long - term , post - transplant period ( reviewed in [ 1 ] ) .", "label": "", "metadata": {}, "score": "91.94762"}
{"text": "E - mail : ashok_jain@urmc.rochester.edu \u00a9 2005 by Elsevier Inc.All rights reserved .360 Park Avenue South , New York , NY 10010 - 1710 0041 - 1345/05/$-see front matter doi:10.1016/j.transproceed.2005.07.049 Transplantation Proceedings , 37 , 3187 - 3189 ( 2005 ) 3187 .", "label": "", "metadata": {}, "score": "92.828705"}
{"text": "Descriptive statistics were presented as medians , interquartile ranges ( IQRs ) , and ranges as appropriate .A comparison of the baseline characteristics was conducted with Fisher 's exact test ( categorical variables ) or the Wilcoxon rank - sum test ( continuous variables ) .", "label": "", "metadata": {}, "score": "93.016205"}
{"text": "53 , no .5 , pp .1374 - 1381 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "93.205956"}
{"text": "53 , no .5 , pp .1374 - 1381 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "93.205956"}
{"text": "56 - 63 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .28 , no .", "label": "", "metadata": {}, "score": "93.93756"}
{"text": "They were quite alarmed when one patient developed septic ( presence of toxins in the blood or tissues ) arthritis of a toe , secondary to S. aureus .", "label": "", "metadata": {}, "score": "94.20686"}
{"text": "You can find out more about our use of cookies in About Cookies , including instructions on how to turn off cookies if you wish to do so .", "label": "", "metadata": {}, "score": "94.83415"}
{"text": "574 - 580 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus", "label": "", "metadata": {}, "score": "96.24236"}
{"text": "Cryoglobulinemia is defined as the presence of immunoglobulins in serum which reversibly precipitate in vitro at low temperatures .Up to 90 % of patients with cryoglobulinemia have anti - HCV , indicating that the disease is not really essential , but rather related to HCV .", "label": "", "metadata": {}, "score": "96.40332"}
{"text": "4 , pp .671 - 678 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "96.93375"}
{"text": "The mechanism of nitazoxanide activity against HCV may be mediated by phosphorylation of the host proteins kinase R ( PKR ) and eIF2alpha , which in turn inhibits HCV replication [ 66 ] .", "label": "", "metadata": {}, "score": "96.98752"}
{"text": "339 , no .21 , pp .1485 - 1492 , 1998 .View at Publisher \u00b7 View at Google Scholar .352 , no .", "label": "", "metadata": {}, "score": "98.57477"}
{"text": "145 - 152 , 2003 .View at Google Scholar \u00b7 View at Scopus .40 , supplement 1 , p. 391A , 2004 .View at Google Scholar .", "label": "", "metadata": {}, "score": "98.821846"}
{"text": "HCV - Related Glomerular Disease .The principal renal manifestation of HCV infection is MPGN , usually in the context of cryoglobulinemia .HCV is probably the major cause of idiopathic MPGN .", "label": "", "metadata": {}, "score": "99.58052"}
{"text": "all Addendum Article Book Review Case Report Comment Commentary Communication Concept Paper Conference Report Correction Creative Data Descriptor Discussion Editorial Erratum Essay Interesting Images Letter New Book Received Obituary Opinion Project Report Reply Retraction Review Short Note Technical Note .", "label": "", "metadata": {}, "score": "101.624344"}
{"text": "Please note : Wiley - Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors .Any queries ( other than missing content ) should be directed to the corresponding author for the article .", "label": "", "metadata": {}, "score": "105.342285"}
{"text": "The cause of cryoglobulinemia is not well understood ; it appears to be due to excessive proliferation of B cells induced by the chronic antigenic stimulation of HCV infection .", "label": "", "metadata": {}, "score": "106.16586"}
{"text": "Notice : Wiley Online Library will be unavailable on Saturday 27th February from 09:00 - 14:00 GMT / 04:00 - 09:00 EST / 17:00 - 22:00 SGT for essential maintenance .", "label": "", "metadata": {}, "score": "108.21968"}
{"text": "View at Publisher \u00b7 View at Google Scholar .51 , no . 2 , pp .263 - 277 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "113.79783"}
{"text": "Received 17 April 2010 ; Revised 16 June 2010 ; Accepted 1 July 2010 .Copyright \u00a9 2010 Ashik Hayat and Ahmad Mitwalli .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "119.3993"}
{"text": "This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "120.874565"}
{"text": "\u00a9 2012 AASLD .If you ca n't find a tool you 're looking for , please click the link at the top of the page to \" Go to old article view \" .", "label": "", "metadata": {}, "score": "130.2079"}
